Page last updated: 2024-11-08

alanine and Disease Models, Animal

alanine has been researched along with Disease Models, Animal in 268 studies

Alanine: A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.
alanine : An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.

Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.

Research Excerpts

ExcerptRelevanceReference
"5-Fluorouracil (5-FU)-induced intestinal mucositis is one of the most common morbidities in chemotherapy and involves the reactive oxygen species (ROS) system, apoptosis, and inflammatory cytokines."7.81Rebamipide attenuates 5-Fluorouracil-induced small intestinal mucositis in a mouse model. ( Han, SH; Kim, HJ; Kim, JH; Lee, JH; Moon, W; Park, J; Park, SJ; Song, GA, 2015)
"We investigated the correlation of plasma amino acid concentrations and the effects of glucosamine and fish collagen peptide (FCP) on osteoarthritis (OA)."7.79Correlation of plasma amino acid concentrations and chondroprotective effects of glucosamine and fish collagen peptide on the development of osteoarthritis. ( Imagawa, T; Matahira, Y; Minami, S; Ohnishi, A; Okamoto, Y; Osaki, T; Tsuka, T, 2013)
"Lewy bodies are found in Parkinson disease and related disorders and are extensively phosphorylated at Ser-129 (S129), but whether S129 phosphorylation mediates alpha-synuclein aggregation and neurotoxicity has been controversial."7.75Alpha-synuclein S129 phosphorylation mutants do not alter nigrostriatal toxicity in a rat model of Parkinson disease. ( Fan, Z; Feany, MB; Hyman, BT; McFarland, NR; McLean, PJ; Schwarzschild, MA; Xu, K, 2009)
"Results of these studies demonstrate that provision of additional NO substrate in the form of L-arginine incites prostaglandin-dependent secretory diarrhea and does not promote epithelial defense or barrier function of C."7.74Oral delivery of L-arginine stimulates prostaglandin-dependent secretory diarrhea in Cryptosporidium parvum-infected neonatal piglets. ( Coccaro, MR; Foster, DM; Gookin, JL; Stauffer, SH, 2008)
"Previous studies by our group demonstrated a striking relationship among arginine, nitric oxide production, and salt-sensitive hypertension in the Dahl/Rapp rat."7.70Studies of arginine metabolism and salt sensitivity in the Dahl/Rapp rat models of hypertension. ( Chen, PY; Hamm, DA; Sanders, PW; Wood, PA, 1998)
"The early-weaned pig develops intestinal atrophy and provides a readily accessible animal model for determining the role of dietary supplementation of glutamine (Gln, a major fuel for enterocytes) in preventing intestinal damage."7.69Dietary glutamine supplementation prevents jejunal atrophy in weaned pigs. ( Knabe, DA; Meier, SA; Wu, G, 1996)
"Consumption of certain product lots of L-tryptophan (LT) has been reported to be epidemiologically associated with an outbreak of eosinophilia-myalgia syndrome (EMS) in the United States."7.69Subchronic toxicity of 3-phenylamino alanine, an impurity in L-tryptophan reported to be associated with eosinophilia-myalgia syndrome. ( Hagiwara, Y; Kawase, Y; Sato, F, 1995)
"The aim of the study was to compare, in a rat model of congestive heart failure, the effect of captopril, a selective angiotensin-converting enzyme (ACE; EC 3."7.69Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril. ( Bralet, J; Gros, C; Lecomte, JM; Marie, C; Mossiat, C; Schwartz, JC, 1994)
"Epilepsy is often considered to be a progressive neurological disease, and the nature of this progression remains unclear."5.72Insights into the development of pentylenetetrazole-induced epileptic seizures from dynamic metabolomic changes. ( Cheng, P; Jia, P; Liao, S; Meng, K; Xiao, C; Xu, R; Zhao, X; Zheng, X, 2022)
"Sprague-Dawley rats were used in middle cerebral artery occlusion model of stroke."5.62Post Stroke Safinamide Treatment Attenuates Neurological Damage by Modulating Autophagy and Apoptosis in Experimental Model of Stroke in Rats. ( Dinda, AK; Joshi, B; Reeta, KH; Sharma, U; Singh, D; Wasan, H, 2021)
"Flecainide was also potent in suppressing microglial activation in experimental autoimmune encephalomyelitis."5.39Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis. ( Bechtold, D; Chauhdry, S; Hassoon, P; Lee, W; Malpass, K; Morsali, D; Palchaudhuri, U; Piers, T; Pocock, J; Roach, A; Smith, KJ; Snell, DM, 2013)
"Colitis was more severe in rats subjected to neonatal or adult capsaicin treatment, but was not affected by subdiaphragmatic vagotomy."5.31Experimental colitis decreases rat jejunal amino acid absorption: role of capsaicin sensitive primary afferents. ( Barada, KA; Kafrouni, MI; Khoury, CI; Mourad, FH; Nassar, CF; Saade, NE; Szabo, SS, 2001)
"Penicillin seizures do not cause a change in levels of GABA, but result in a decrease in glutamate within the focus."5.26Effect of amino-oxyacetic acid (AOAA) on focal penicillin seizures. ( Collins, RC; Mehta, S, 1978)
" We used a macaque model of repeated exposures to simian human immunodeficiency virus (SHIV) to investigate whether TAF alone or the combination of TAF and emtricitabine (FTC) can prevent vaginal infection."3.91Efficacy of Oral Tenofovir Alafenamide/Emtricitabine Combination or Single-Agent Tenofovir Alafenamide Against Vaginal Simian Human Immunodeficiency Virus Infection in Macaques. ( Babusis, D; Callebaut, C; Cong, ME; Deyounks, F; Dinh, C; García-Lerma, JG; Heneine, W; Holder, A; Johnson, R; Khalil, G; Lipscomb, J; Massud, I; McCallister, S; Nishiura, K; Pan, Y; Park, Y; Rooney, JF; Ruone, S, 2019)
" This study aims to determine small intestinal alanine absorption and cytokine expression in a novel model of colonic ulceration induced by electro-cautery."3.81Electrocautery-induced localized colonic injury elicits increased levels of pro-inflammatory cytokines in small bowel and decreases jejunal alanine absorption. ( Barada, K; Mourad, FH; Noutsi, B; Saadé, NE, 2015)
"5-Fluorouracil (5-FU)-induced intestinal mucositis is one of the most common morbidities in chemotherapy and involves the reactive oxygen species (ROS) system, apoptosis, and inflammatory cytokines."3.81Rebamipide attenuates 5-Fluorouracil-induced small intestinal mucositis in a mouse model. ( Han, SH; Kim, HJ; Kim, JH; Lee, JH; Moon, W; Park, J; Park, SJ; Song, GA, 2015)
"Polaprezinc (PZ), which consists of l-carnosine and zinc, is widely used to treat gastric ulcers."3.79The effect of polaprezinc on gastric mucosal protection in rats with ethanol-induced gastric mucosal damage: comparison study with rebamipide. ( Choi, HS; Chun, HJ; Jeen, YT; Keum, B; Kim, CD; Kim, ES; Lee, HS; Lee, M; Lim, JY; Ryu, HS; Seo, YS; Sul, D; Um, SH, 2013)
"We investigated the correlation of plasma amino acid concentrations and the effects of glucosamine and fish collagen peptide (FCP) on osteoarthritis (OA)."3.79Correlation of plasma amino acid concentrations and chondroprotective effects of glucosamine and fish collagen peptide on the development of osteoarthritis. ( Imagawa, T; Matahira, Y; Minami, S; Ohnishi, A; Okamoto, Y; Osaki, T; Tsuka, T, 2013)
" Following hyperpolarized [1-(13)C]pyruvate injections, pyruvate and its metabolic products, alanine and lactate, were observed in the liver of five rats with hepatocellular carcinoma and five healthy control rats."3.76T(2) relaxation times of (13)C metabolites in a rat hepatocellular carcinoma model measured in vivo using (13)C-MRS of hyperpolarized [1-(13)C]pyruvate. ( Butts Pauly, K; Hurd, R; King, R; Le Roux, P; Mayer, D; Pfefferbaum, A; Spielman, D; Tropp, J; Vasanawala, S; Yen, YF, 2010)
"Lewy bodies are found in Parkinson disease and related disorders and are extensively phosphorylated at Ser-129 (S129), but whether S129 phosphorylation mediates alpha-synuclein aggregation and neurotoxicity has been controversial."3.75Alpha-synuclein S129 phosphorylation mutants do not alter nigrostriatal toxicity in a rat model of Parkinson disease. ( Fan, Z; Feany, MB; Hyman, BT; McFarland, NR; McLean, PJ; Schwarzschild, MA; Xu, K, 2009)
"Results of these studies demonstrate that provision of additional NO substrate in the form of L-arginine incites prostaglandin-dependent secretory diarrhea and does not promote epithelial defense or barrier function of C."3.74Oral delivery of L-arginine stimulates prostaglandin-dependent secretory diarrhea in Cryptosporidium parvum-infected neonatal piglets. ( Coccaro, MR; Foster, DM; Gookin, JL; Stauffer, SH, 2008)
" We show that modulation of the eNOS serine 1179 (S1179) phosphorylation site affects vascular reactivity and determines stroke size in vivo."3.74The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo. ( Atochin, DN; Ayata, C; Critchlow, JD; Dantas, AP; Huang, PL; Liu, VW; Looft-Wilson, R; Michel, T; Moskowitz, MA; Murata, T; Salomone, S; Sessa, WC; Shin, HK; Wang, A, 2007)
" plantarum strains were administered in ornithine transcarbamoylase-deficient Sparse-fur mice, a model of constitutive hyperammonemia, in a carbon tetrachloride rat model of chronic liver insufficiency and in a thioacetamide-induced acute liver failure mice model."3.74Control of acute, chronic, and constitutive hyperammonemia by wild-type and genetically engineered Lactobacillus plantarum in rodents. ( Demetter, P; Devière, J; Goffin, P; Gustot, T; Hols, P; Moreno, C; Nicaise, C; Prozzi, D; Quertinmont, E; Suain, V; Viaene, E, 2008)
"Hyperthyroidism was induced by treating rats with L-thyroxine (12 mg/L) in the drinking water for 21 days."3.72Decreased activity and expression of intestinal oligopeptide transporter PEPT1 in rats with hyperthyroidism in vivo. ( Ashida, K; Inui, K; Katsura, T; Saito, H, 2004)
"We investigated the effects of an intravenous load of alpha-ketoglutaric acid, ammonium (NH(4)(+)), and metabolic acidosis on plasma concentration and splanchnic and hindleg tissue exchange of glutamine, glutamate, alanine, and arginine in postabsorptive, anesthetized pigs."3.71Glutamine concentration and tissue exchange with intravenously administered alpha-ketoglutaric acid and ammonium: a dose-response study in the pig. ( Karlsson, T; Nordgren, A; Wiklund, L, 2002)
"Previous studies by our group demonstrated a striking relationship among arginine, nitric oxide production, and salt-sensitive hypertension in the Dahl/Rapp rat."3.70Studies of arginine metabolism and salt sensitivity in the Dahl/Rapp rat models of hypertension. ( Chen, PY; Hamm, DA; Sanders, PW; Wood, PA, 1998)
"Consumption of certain product lots of L-tryptophan (LT) has been reported to be epidemiologically associated with an outbreak of eosinophilia-myalgia syndrome (EMS) in the United States."3.69Subchronic toxicity of 3-phenylamino alanine, an impurity in L-tryptophan reported to be associated with eosinophilia-myalgia syndrome. ( Hagiwara, Y; Kawase, Y; Sato, F, 1995)
"The aim of the study was to compare, in a rat model of congestive heart failure, the effect of captopril, a selective angiotensin-converting enzyme (ACE; EC 3."3.69Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril. ( Bralet, J; Gros, C; Lecomte, JM; Marie, C; Mossiat, C; Schwartz, JC, 1994)
"The early-weaned pig develops intestinal atrophy and provides a readily accessible animal model for determining the role of dietary supplementation of glutamine (Gln, a major fuel for enterocytes) in preventing intestinal damage."3.69Dietary glutamine supplementation prevents jejunal atrophy in weaned pigs. ( Knabe, DA; Meier, SA; Wu, G, 1996)
"Unidirectional fluxes of alanine, methionine, and Na were measured in jejunal segments from 3- to 4-wk-old normal (N) mice or mice with congenital (P) or induced (I) megacolon in the absence of electrochemical gradients."3.66Jejunal transport properties of piebald mouse model for Hirschsprung's disease. ( Cooke, AR; Cooke, HJ; Henning, HJ; Wood, JD, 1980)
"Alzheimer's disease is thought to be caused by increased formations of neurotoxic amyloid beta (A beta) peptides, which give rise to the hallmark amyloid plaques."2.45Development of semagacestat (LY450139), a functional gamma-secretase inhibitor, for the treatment of Alzheimer's disease. ( Dean, RA; Henley, DB; May, PC; Siemers, ER, 2009)
"Safinamide has neuroprotective and neurorescuing effects in MPTP-treated mice, in the rat kainic acid, and in the gerbil ischemia model."2.43Safinamide: from molecular targets to a new anti-Parkinson drug. ( Caccia, C; Calabresi, M; Curatolo, L; Faravelli, L; Fariello, RG; Maestroni, S; Maj, R; Salvati, P, 2006)
"In the experiment designed to provoke gastric cancer through MNU treatment with H."2.42Chemoprevention of Helicobacter pylori-associated gastric carcinogenesis in a mouse model: is it possible? ( Cho, SW; Hahm, KB; Han, SU; Kim, DY; Kim, JH; Kim, MW; Kim, YB; Lee, JS; Nahm, KT; Oh, TY; Song, YJ; Surh, YJ; Yoo, BM, 2003)
"Epilepsy is often considered to be a progressive neurological disease, and the nature of this progression remains unclear."1.72Insights into the development of pentylenetetrazole-induced epileptic seizures from dynamic metabolomic changes. ( Cheng, P; Jia, P; Liao, S; Meng, K; Xiao, C; Xu, R; Zhao, X; Zheng, X, 2022)
"Efficacious therapeutics for Ebola virus disease are in great demand."1.62Remdesivir is efficacious in rhesus monkeys exposed to aerosolized Ebola virus. ( Bannister, R; Bavari, S; Cihlar, T; Donnelly, G; Garza, NL; Gomba, L; Iversen, PL; Kane, CD; Norris, S; Porter, DP; Steffens, J; Stuthman, KS; Van Tongeren, SA; Warren, TK; Weidner, JM; Wells, J; Zeng, X, 2021)
"5 folds enhancement in relative bioavailability and remarkable amplification in anti-ulcer, anti-inflammatory and the antioxidant potential of these cocrystals were observed."1.62Engineering a Remedy to Modulate and Optimize Biopharmaceutical Properties of Rebamipide by Synthesizing New Cocrystal: In Silico and Experimental Studies. ( Chadha, R; Dureja, J; Jindal, A; Karan, M; Singh, R; Tomar, S, 2021)
"Effective treatments for coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are urgently needed."1.62Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection. ( Cai, JP; Cao, J; Chan, CC; Chan, JF; Chu, H; Jin, DY; Ong, CP; Poon, VK; Tang, K; Yang, D; Ye, ZW; Yu, CY; Yuan, S; Yuen, KY; Zhang, AJ, 2021)
"Skeletal muscle atrophy occurs in response to various pathophysiological stimuli, including disuse, aging, and neuromuscular disorders, mainly due to an imbalance of anabolic/catabolic signaling."1.62BCAAs and Di-Alanine supplementation in the prevention of skeletal muscle atrophy: preclinical evaluation in a murine model of hind limb unloading. ( Allegretti, M; Aramini, A; Bianchini, G; Boccanegra, B; Camerino, GM; Cappellari, O; Conte, E; De Bellis, M; De Luca, A; Mantuano, P; Pierno, S; Sanarica, F, 2021)
"Sprague-Dawley rats were used in middle cerebral artery occlusion model of stroke."1.62Post Stroke Safinamide Treatment Attenuates Neurological Damage by Modulating Autophagy and Apoptosis in Experimental Model of Stroke in Rats. ( Dinda, AK; Joshi, B; Reeta, KH; Sharma, U; Singh, D; Wasan, H, 2021)
"The continued emergence of Middle East Respiratory Syndrome (MERS) cases with a high case fatality rate stresses the need for the availability of effective antiviral treatments."1.56Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection. ( Cihlar, T; Cronin, J; de Wit, E; Feldmann, F; Feldmann, H; Jordan, R; Okumura, A; Scott, D; Thomas, T, 2020)
"Effective therapies to treat coronavirus disease 2019 (COVID-19) are urgently needed."1.56Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2. ( Anzick, S; Barbian, K; Bosio, CM; Cihlar, T; de Wit, E; Feldmann, F; Hanley, PW; Leighton, I; Lovaglio, J; Martens, C; Meade-White, K; Munster, VJ; Okumura, A; Pérez-Pérez, L; Porter, DP; Saturday, G; Schulz, J; Schwarz, B; Scott, DP; van Doremalen, N; Williamson, BN; Yinda, CK, 2020)
" We found that early accumulation of KARs occurs in the DA neurons of the parkinQ311X mouse, and that chronic administration of the KAR antagonist UBP310 prevents DA neuron loss."1.56Pharmacological antagonism of kainate receptor rescues dysfunction and loss of dopamine neurons in a mouse model of human parkin-induced toxicity. ( Albanese, F; Bagnati, R; Cattaneo, S; Ciammola, A; Consalez, GG; Croci, L; Davoli, E; Di Fonzo, A; Mercatelli, D; Morari, M; Novello, S; Passafaro, M; Passoni, A; Regoni, M; Sassone, J; Serratto, GM; Taverna, S; Valtorta, F; Zanetti, L, 2020)
"Brivanib is an oral selective dual receptor tyrosine kinase (RTK) inhibitor of FGFRs and VEGFRs, especially VEGFR2 and FGFR1."1.56Brivanib, a multitargeted small-molecule tyrosine kinase inhibitor, suppresses laser-induced CNV in a mouse model of neovascular AMD. ( Chen, J; Ding, D; Gu, J; Li, L; Liu, D; Liu, X; Qin, B; Sang, A; Shi, Y; Tu, Y; Wu, W; Zhu, M, 2020)
"Gastrointestinal mucositis is a serious side effect of chemotherapy."1.51Efficacy of Azatyrosine-Phenylbutyric Hydroxamides, a Histone Deacetylase Inhibitor, on Chemotherapy-Induced Gastrointestinal Mucositis. ( Cheng, YW; Huang, SH; Huang, WK; Hung, CH; Kang, JJ; Liao, PL; Tsai, CH; Wang, HP, 2019)
"To determine the mucinogenic effect of dry eye (DE) treatment drugs currently in use, we compared the levels of mucin production and inflammatory cytokine expression on the ocular surfaces using a DE-induced mice model."1.48Comparison of Ocular Surface Mucin Expression After Topical Ophthalmic Drug Administration in Dry Eye-Induced Mouse Model. ( Ji, YW; Kang, HG; Kim, HC; Lee, HK; Moon, I; Noh, H; Song, JS; Yeo, A, 2018)
"Radiation-induced colitis is a common clinical problem associated with radiotherapy and accidental exposure to ionizing radiation."1.48Rebamipide alleviates radiation-induced colitis through improvement of goblet cell differentiation in mice. ( Jang, H; Jang, WS; Jin, YW; Kim, H; Lee, C; Lee, J; Lee, SJ; Lee, SS; Myung, H; Myung, JK; Park, S; Shim, S, 2018)
"Pantoprazole (5 mg/kg) was administered intraperitoneally to the PPI and PPI+R groups."1.48Additive Effects of Rebamipide Plus Proton Pump Inhibitors on the Expression of Tight Junction Proteins in a Rat Model of Gastro-Esophageal Reflux Disease. ( Choi, YK; Chung, JW; Gweon, TG; Kim, BW; Kim, CW; Kim, HG; Kim, JS; Park, JH; Park, SM, 2018)
"Staphylococcus aureus infections are becoming a major global health issue due to the rapid emergence of multidrug-resistant strains."1.48A D-Alanine auxotrophic live vaccine is effective against lethal infection caused by Staphylococcus aureus. ( Bou, G; Cabral, MP; García, P; Moscoso, M; Rumbo, C, 2018)
"Furthermore, in a mouse model of mitochondrial myopathy, we show that increased oxidative αKG flux in muscle arises from enhanced alanine synthesis and release into blood, concomitant with accelerated amino acid catabolism from protein breakdown."1.48Rewiring of Glutamine Metabolism Is a Bioenergetic Adaptation of Human Cells with Mitochondrial DNA Mutations. ( Arreguin, AJ; Beal, MF; Calder, EL; Carelli, V; Chen, Q; D'Aurelio, M; Denton, TT; Gross, SS; Kirk, K; Manfredi, G; Primiano, G; Shahi, I; Shurubor, YI; Valsecchi, F; Zhao, D, 2018)
"Irsogladine maleate (IM) is a drug with gastric mucosal protective properties."1.48[Development of "Patient Friendly Formulations" to Counter the Side Effects of Cancer Chemotherapy]. ( Hanawa, T; Kawano, Y; Satoh, M, 2018)
"Safinamide (Xadago) is a novel dual-mechanism drug that has been approved in the European Union and United States as add-on treatment to levodopa in Parkinson's disease therapy."1.48Safinamide Modulates Striatal Glutamatergic Signaling in a Rat Model of Levodopa-Induced Dyskinesia. ( Brugnoli, A; Caccia, C; Gardoni, F; Keywood, C; Kulisevsky, J; Mellone, M; Melloni, E; Morari, M; Novello, S; Padoani, G; Pisanò, CA; Sosti, V; Vailati, S, 2018)
" Here, we show in the model system Caenorhabditis elegans that expression of the arginine-containing dipeptides, but not alanine-containing dipeptides, produces toxic phenotypes in multiple cellular contexts, including motor neurons."1.46Nuclear localized C9orf72-associated arginine-containing dipeptides exhibit age-dependent toxicity in C. elegans. ( Lamitina, ST; Monaghan, J; Pandey, UB; Rudich, P; Snoznik, C; Watkins, SC, 2017)
"Colitis was induced via an intrarectal injection of TNBS in mice."1.43Oridonin derivative ameliorates experimental colitis by inhibiting activated T-cells and translocation of nuclear factor-kappa B. ( Chen, K; Liu, QQ; Sun, YW; Wang, HL; Wang, SB; Xu, Y; Ye, Q, 2016)
" We found that S421 phosphorylation mitigates neurodegeneration by increasing proteasome-dependent turnover of mHTT and reducing the presence of a toxic mHTT conformer."1.43Serine 421 regulates mutant huntingtin toxicity and clearance in mice. ( Daub, AC; Finkbeiner, S; Gu, X; Humbert, S; Kratter, IH; Lau, A; Masliah, E; Osmand, A; Saudou, F; Steffan, JS; Tsvetkov, AS; Weiberth, KF; Yang, XW; Zahed, H, 2016)
"The most common cause of HSAN1 is due to dominant mutations in serine palmitoyl-transferase subunit 1 (SPT1)."1.42Identification of dietary alanine toxicity and trafficking dysfunction in a Drosophila model of hereditary sensory and autonomic neuropathy type 1. ( Lloyd-Evans, E; Oswald, MC; Sweeney, ST; West, RJ, 2015)
"MNNG-induced carcinogenesis and may also inhibit progression of cancer in rats."1.42Preventive effect of rebamipide on N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats. ( Ebi, M; Hayashi, N; Joh, T; Katano, T; Kataoka, H; Mizoshita, T; Mori, Y; Ozeki, K; Shimura, T; Tanida, S; Tatematsu, M; Tsukamoto, H; Tsukamoto, T, 2015)
"An unresolved debate in Alzheimer's disease (AD) is whether amyloid plaques are pathogenic, causing overt physical disruption of neural circuits, or protective, sequestering soluble forms of amyloid-β (Aβ) that initiate synaptic damage and cognitive decline."1.40Genetic modulation of soluble Aβ rescues cognitive and synaptic impairment in a mouse model of Alzheimer's disease. ( Chiang, AC; Cirrito, JR; Fowler, SW; Jankowsky, JL; Larson, ME; Lesné, SE; Savjani, RR; Schuler, DR; Sherman, MA, 2014)
"This study showed that breast cancer cells tolerate and use lactate at clinically relevant concentrations in vitro (± glucose) and in vivo."1.39Catabolism of exogenous lactate reveals it as a legitimate metabolic substrate in breast cancer. ( Chi, JT; Dewhirst, MW; Kennedy, KM; Landon, CD; Pizzo, S; Ribeiro, A; Richardson, R; Scarbrough, PM; Schroeder, T; Sonveaux, P; Yuan, H, 2013)
"Flecainide was also potent in suppressing microglial activation in experimental autoimmune encephalomyelitis."1.39Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis. ( Bechtold, D; Chauhdry, S; Hassoon, P; Lee, W; Malpass, K; Morsali, D; Palchaudhuri, U; Piers, T; Pocock, J; Roach, A; Smith, KJ; Snell, DM, 2013)
"A rat model of dry eye was developed by surgical removal of exorbital lacrimal glands."1.39Protection of human corneal epithelial cells from TNF-α-induced disruption of barrier function by rebamipide. ( Haruta, J; Kimura, K; Morita, Y; Orita, T; Sonoda, KH; Takeji, Y, 2013)
"Glycine has been shown to participate in protection from hypoxia/reoxygenation injury."1.39Effects of glycine supplementation on myocardial damage and cardiac function after severe burn. ( Liang, GP; Lv, SJ; Peng, X; Wan, QX; Wang, L; Yan, H; Zhang, Y, 2013)
"Episodic ataxia type 1 (EA1) is an autosomal dominant neurological disorder characterized by myokymia and attacks of ataxic gait often precipitated by stress."1.38Kv1.1 knock-in ataxic mice exhibit spontaneous myokymic activity exacerbated by fatigue, ischemia and low temperature. ( Botti, FM; Brunetti, O; D'Adamo, MC; Di Giovanni, G; Gibertini, S; Imbrici, P; Mora, M; Muscat, R; Pessia, M; Pettorossi, VE; Valentino, M; Zammit, C, 2012)
"Classical pathological signs of Parkinson's disease (PD) include loss of dopaminergic neurons in substantia nigra (SN) and noradrenergic neurons in locus coeruleus (LC), and deposition of Lewy bodies rich in the presynaptic protein alpha-synuclein (ASYN)."1.36Selective noradrenergic vulnerability in α-synuclein transgenic mice. ( Sotiriou, E; Stefanis, L; Vassilatis, DK; Vila, M, 2010)
"We report the establishment of an in vivo model using the fruit fly Drosophila melanogaster to investigate the toxic effects of L-BMAA."1.35BMAA neurotoxicity in Drosophila. ( Bradley, WG; Escala, W; Papapetropoulos, S; Zhai, RG; Zhou, X, 2009)
"The deficits of Alzheimer's disease (AD) are believed to result, at least in part, from neurotoxicity of beta-amyloid (Abeta), a set of 38-43 amino acid fragments derived from the beta-amyloid precursor protein (APP)."1.35Long-term prevention of Alzheimer's disease-like behavioral deficits in PDAPP mice carrying a mutation in Asp664. ( Ataie, M; Banwait, S; Bredesen, DE; Galvan, V; Gorostiza, OF; Huang, W; Tang, H; Zhang, J, 2008)
"APPDutch transgenic (tg) mice develop cerebral amyloid angiopathy (CAA) that consists mainly of AbetaDutch40, with virtually no parenchymal amyloid plaques."1.34BACE1 and mutated presenilin-1 differently modulate Abeta40 and Abeta42 levels and cerebral amyloidosis in APPDutch transgenic mice. ( Herzig, MC; Jucker, M; Paganetti, P; Staufenbiel, M, 2007)
"D-mannose is an essential monosaccharide constituent of glycoproteins and glycolipids."1.33Hepatic glycogen breakdown is implicated in the maintenance of plasma mannose concentration. ( Asano, N; Miwa, I; Mizutani, T; Nakajima, H; Taguchi, T; Yabuuchi, M; Yamashita, E, 2005)
"Amyotrophic lateral sclerosis (ALS), a multifactorial disease characterized by diffuse motor neuron degeneration, has proven to be a difficult target for stem cell therapy."1.32Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation. ( Chen, N; Davis, CD; Garbuzova-Davis, S; Hudson, JE; Justen, EB; Lane, JC; Sanberg, PR; Saporta, S; Willing, AE; Zigova, T, 2003)
"Depression is characterized by a lack of "motivation" rather than a lack of "physical space" to move around."1.32Open space swimming test to index antidepressant activity. ( Alkon, DL; Sun, MK, 2003)
"Colitis was more severe in rats subjected to neonatal or adult capsaicin treatment, but was not affected by subdiaphragmatic vagotomy."1.31Experimental colitis decreases rat jejunal amino acid absorption: role of capsaicin sensitive primary afferents. ( Barada, KA; Kafrouni, MI; Khoury, CI; Mourad, FH; Nassar, CF; Saade, NE; Szabo, SS, 2001)
"The present study evaluated the therapeutic effects of rebamipide alone and in combination with cimetidine on experimental gastritis established by the administration of 5 mM sodium taurocholate (TCA) for 6 months in rats."1.28Therapeutic effects of oral rebamipide and in combination with cimetidine on experimental gastritis in rats. ( Fujimura, J; Haruma, K; Kajiyama, G; Kishimoto, S; Kobayashi, H; Machino, H; Sakurai, K; Shimamoto, T; Shimizu, S; Yamasaki, K, 1992)
"These data suggest that intrauterine growth retardation in dogs results in fasting neonatal hypoglycemia that is due in part to reduced systemic glucose production."1.28Alterations of fasting glucose and fat metabolism in intrauterine growth-retarded newborn dogs. ( Kliegman, RM, 1989)
"Penicillin seizures do not cause a change in levels of GABA, but result in a decrease in glutamate within the focus."1.26Effect of amino-oxyacetic acid (AOAA) on focal penicillin seizures. ( Collins, RC; Mehta, S, 1978)
"Diaminopimelic acid was absent in the Legionnaires' disease bacterium peptidoglycan."1.26Fine structure of the Legionnaires' disease bacterium. In-vitro and in-vivo studies of four isolates. ( Feeley, JC; Finnerty, WR; Keel, JA, 1979)

Research

Studies (268)

TimeframeStudies, this research(%)All Research%
pre-199017 (6.34)18.7374
1990's23 (8.58)18.2507
2000's79 (29.48)29.6817
2010's109 (40.67)24.3611
2020's40 (14.93)2.80

Authors

AuthorsStudies
Abrams, RPM1
Yasgar, A1
Teramoto, T1
Lee, MH1
Dorjsuren, D1
Eastman, RT1
Malik, N1
Zakharov, AV1
Li, W3
Bachani, M1
Brimacombe, K1
Steiner, JP1
Hall, MD1
Balasubramanian, A1
Jadhav, A1
Padmanabhan, R1
Simeonov, A1
Nath, A1
Korolowicz, KE1
Suresh, M1
Li, B2
Huang, X1
Yon, C1
Kallakury, BV1
Lee, KP1
Park, S2
Kim, YW1
Menne, S1
Warren, TK2
Kane, CD1
Wells, J2
Stuthman, KS1
Van Tongeren, SA1
Garza, NL1
Donnelly, G2
Steffens, J2
Gomba, L2
Weidner, JM2
Norris, S1
Zeng, X1
Bannister, R2
Cihlar, T5
Bavari, S2
Porter, DP5
Iversen, PL1
Boras, B1
Jones, RM1
Anson, BJ1
Arenson, D1
Aschenbrenner, L1
Bakowski, MA1
Beutler, N1
Binder, J1
Chen, E1
Eng, H1
Hammond, H1
Hammond, J1
Haupt, RE1
Hoffman, R1
Kadar, EP1
Kania, R1
Kimoto, E1
Kirkpatrick, MG1
Lanyon, L1
Lendy, EK1
Lillis, JR1
Logue, J1
Luthra, SA1
Ma, C1
Mason, SW1
McGrath, ME1
Noell, S1
Obach, RS1
O' Brien, MN1
O'Connor, R1
Ogilvie, K1
Owen, D1
Pettersson, M1
Reese, MR1
Rogers, TF1
Rosales, R1
Rossulek, MI1
Sathish, JG1
Shirai, N1
Steppan, C1
Ticehurst, M1
Updyke, LW1
Weston, S1
Zhu, Y1
White, KM1
García-Sastre, A1
Wang, J2
Chatterjee, AK1
Mesecar, AD1
Frieman, MB1
Anderson, AS1
Allerton, C1
Li, Q1
Wu, X2
Xin, M1
Jindal, A1
Singh, R1
Tomar, S1
Dureja, J1
Karan, M1
Chadha, R1
Williamson, BN2
Pérez-Pérez, L2
Schwarz, B2
Feldmann, F3
Holbrook, MG1
Singh, M1
Lye, DS1
Babusis, D3
Subramanian, R1
Haddock, E1
Okumura, A3
Hanley, PW2
Lovaglio, J2
Bosio, CM2
Mackman, RL1
Saturday, G2
de Wit, E3
Spyropoulos, F1
Sorrentino, A1
van der Reest, J1
Yang, P1
Waldeck-Weiermair, M1
Steinhorn, B1
Eroglu, E1
Saeedi Saravi, SS1
Yu, P1
Haigis, M1
Christou, H1
Michel, T2
Kerkaert, JD1
Le Mauff, F1
Wucher, BR1
Beattie, SR1
Vesely, EM1
Sheppard, DC1
Nadell, CD1
Cramer, RA1
Gao, J1
Wu, P1
Chi, Y1
Xu, H1
Zhao, Y3
Song, N1
Mao, Y1
Zhao, X2
Cheng, P1
Xu, R2
Meng, K1
Liao, S1
Jia, P1
Zheng, X1
Xiao, C1
Huang, F1
Zhang, T1
Wang, S1
Xu, C1
Huang, C1
Lin, D1
Oishi, K1
Yajima, Y1
Yoshida, Y1
Hagihara, H1
Miyakawa, T1
Higo-Yamamoto, S1
Toyoda, A1
Jin-Sil, P1
Sun-Hee, H1
SeungCheon, Y1
JeongWon, C1
Kyung-Ah, J1
Mi-La, C1
Sung-Hwan, P1
Uehara, M1
Yamazaki, H1
Yoshikawa, N1
Kuribara-Souta, A1
Tanaka, H2
Shamloo, K1
Barbarino, A1
Alfuraih, S1
Sharma, A1
Kilpeläinen, T1
Julku, UH1
Svarcbahs, R1
Myöhänen, TT2
Zhao, J1
Han, M1
Zhou, L1
Liang, P1
Wang, Y5
Feng, S1
Lu, H1
Yuan, X1
Han, K1
Chen, X3
Liu, S2
Cheng, J1
Nakayama, T1
Tsukamoto, M1
Watanabe, A1
Nakamura, T2
Yokoi, N2
Sotozono, C2
Kinoshita, S2
Cronin, J1
Jordan, R2
Thomas, T1
Scott, D1
Feldmann, H1
Maxmen, A1
Sheahan, TP1
Sims, AC1
Zhou, S1
Graham, RL1
Pruijssers, AJ1
Agostini, ML1
Leist, SR1
Schäfer, A1
Dinnon, KH1
Stevens, LJ1
Chappell, JD1
Lu, X1
Hughes, TM1
George, AS1
Hill, CS1
Montgomery, SA1
Brown, AJ1
Bluemling, GR1
Natchus, MG1
Saindane, M1
Kolykhalov, AA1
Painter, G1
Harcourt, J1
Tamin, A1
Thornburg, NJ1
Swanstrom, R1
Denison, MR1
Baric, RS1
Soleimani Moez, A1
H Sajedi, R1
Pooshang Bagheri, K1
Sabatier, JM1
Shahbazzadeh, D1
Basu, S1
Mackowiak, SD1
Niskanen, H1
Knezevic, D1
Asimi, V1
Grosswendt, S1
Geertsema, H1
Ali, S1
Jerković, I1
Ewers, H1
Mundlos, S1
Meissner, A1
Ibrahim, DM1
Hnisz, D1
Blair, C1
Wetzel, K1
Garza, N1
Van Tongeren, S1
Moreau, A1
Bearss, J1
Lee, E1
Meade-White, K1
Schulz, J1
van Doremalen, N1
Leighton, I1
Yinda, CK1
Anzick, S1
Barbian, K1
Martens, C1
Scott, DP1
Munster, VJ1
Shuai, L1
Wang, C1
Liu, R1
He, X1
Zhang, X1
Sun, Z1
Shan, D1
Ge, J1
Wang, X2
Hua, R1
Zhong, G1
Wen, Z1
Bu, Z1
Abdel-Wahab, BA1
Ali, FEM1
Alkahtani, SA1
Alshabi, AM1
Mahnashi, MH1
Hassanein, EHM1
Dobrovolny, HM1
Regoni, M1
Cattaneo, S1
Mercatelli, D1
Novello, S2
Passoni, A1
Bagnati, R1
Davoli, E1
Croci, L1
Consalez, GG1
Albanese, F1
Zanetti, L1
Passafaro, M1
Serratto, GM1
Di Fonzo, A1
Valtorta, F1
Ciammola, A1
Taverna, S1
Morari, M2
Sassone, J2
Xu, N1
Zhang, C1
Jing, L1
Mou, S1
Cao, X1
Yu, Z1
Altiné-Samey, R1
Antier, D1
Mavel, S1
Dufour-Rainfray, D1
Balageas, AC1
Beaufils, E1
Emond, P1
Foucault-Fruchard, L1
Chalon, S1
Cicka, D1
Sukhatme, VP1
Ye, ZW1
Yuan, S1
Chan, JF1
Zhang, AJ1
Yu, CY1
Ong, CP1
Yang, D2
Chan, CC2
Tang, K1
Cao, J1
Poon, VK1
Cai, JP1
Chu, H1
Yuen, KY1
Jin, DY2
Okun, JG2
Rusu, PM1
Chan, AY1
Wu, Y1
Yap, YW1
Sharkie, T1
Schumacher, J1
Schmidt, KV1
Roberts-Thomson, KM1
Russell, RD1
Zota, A1
Hille, S1
Jungmann, A1
Maggi, L1
Lee, Y1
Blüher, M1
Herzig, S1
Keske, MA1
Heikenwalder, M1
Müller, OJ1
Rose, AJ1
Cross, RW1
Bornholdt, ZA1
Prasad, AN1
Borisevich, V1
Agans, KN1
Deer, DJ1
Abelson, DM1
Kim, DH1
Shestowsky, WS1
Campbell, LA1
Bunyan, E1
Geisbert, JB1
Fenton, KA1
Zeitlin, L1
Geisbert, TW1
Naser, FJ1
Jackstadt, MM1
Fowle-Grider, R1
Spalding, JL1
Cho, K1
Stancliffe, E1
Doonan, SR1
Kramer, ET1
Yao, L1
Krasnick, B1
Ding, L1
Fields, RC1
Kaufman, CK1
Shriver, LP1
Johnson, SL1
Patti, GJ1
Yin, L1
Zhao, H1
Zhang, H1
Li, Y2
Dong, Y1
Ju, H1
Kong, F1
Zhao, S1
Wan, Y2
Wu, W3
Li, L2
Zhang, J3
Yao, X1
Bertelsen, LB2
Hansen, ESS1
Sadowski, T1
Ruf, S1
Laustsen, C3
Mantuano, P1
Boccanegra, B1
Bianchini, G1
Conte, E1
De Bellis, M1
Sanarica, F1
Camerino, GM1
Pierno, S1
Cappellari, O1
Allegretti, M1
Aramini, A1
De Luca, A1
Wasan, H1
Singh, D1
Joshi, B1
Sharma, U1
Dinda, AK1
Reeta, KH1
Ellis, AS1
Fosnocht, AQ1
Lucerne, KE1
Briand, LA1
Fan, S1
Zhong, W1
Zhou, X2
Li, S2
Tagami, S1
Yanagida, K1
Kodama, TS1
Takami, M1
Mizuta, N1
Oyama, H1
Nishitomi, K1
Chiu, YW1
Okamoto, T1
Ikeuchi, T1
Sakaguchi, G1
Kudo, T1
Matsuura, Y1
Fukumori, A1
Takeda, M1
Ihara, Y1
Okochi, M1
Rudich, P1
Snoznik, C1
Watkins, SC1
Monaghan, J1
Pandey, UB1
Lamitina, ST1
Jang, H1
Lee, J1
Myung, JK1
Jang, WS1
Lee, SJ1
Myung, H1
Lee, C1
Kim, H1
Lee, SS1
Jin, YW1
Shim, S1
Gweon, TG1
Park, JH1
Kim, BW1
Choi, YK1
Kim, JS2
Park, SM1
Kim, CW1
Kim, HG1
Chung, JW1
Lin, HJ1
Hsu, CC1
Chio, CC1
Tian, YF1
Lin, MT1
Lin, TW1
Chang, CH1
Chang, CP1
Moscoso, M1
García, P1
Cabral, MP1
Rumbo, C1
Bou, G1
Hanawa, T1
Kawano, Y1
Satoh, M1
Kuang, S1
Yang, L1
Rao, Z1
Zhong, Z1
Li, J1
Zhong, H1
Dai, L1
Tang, X1
Kojima, T3
Simsek, C2
Igarashi, A2
Aoki, K1
Higa, K1
Shimizu, T2
Dogru, M2
Tsubota, K3
Shimazaki, J3
Chen, Q1
Kirk, K1
Shurubor, YI1
Zhao, D1
Arreguin, AJ1
Shahi, I1
Valsecchi, F1
Primiano, G1
Calder, EL1
Carelli, V1
Denton, TT1
Beal, MF2
Gross, SS1
Manfredi, G1
D'Aurelio, M1
Perna, AF1
Anishchenko, E1
Vigorito, C1
Zacchia, M1
Trepiccione, F1
D'Aniello, S1
Ingrosso, D1
Grosenbaugh, DK1
Ross, BM1
Wagley, P1
Zanelli, SA1
Henrich, MT1
Geibl, FF1
Lee, B2
Chiu, WH1
Koprich, JB1
Brotchie, JM2
Timmermann, L1
Decher, N1
Matschke, LA1
Oertel, WH1
Wang, F2
Song, ZY1
Qu, XJ1
Li, F1
Zhang, L1
Li, WB1
Cui, SX1
Wang, B1
Smyl, C1
Chen, CY1
Li, XY1
Huang, W2
Zhang, HM1
Pai, VJ1
Kang, JX1
Lautenschläger, I1
Pless-Petig, G1
Middel, P1
de Groot, H1
Rauen, U1
Stojanovic, T1
Wang, Z1
Shen, G1
Feng, J1
Heissat, S1
Harel, A1
Um, K1
Brunet, AS1
Hervieu, V1
Guillaud, O1
Dumortier, J1
Lachaux, A1
Mintz, E1
Bost, M1
Gardoni, F1
Kulisevsky, J1
Brugnoli, A1
Pisanò, CA1
Caccia, C2
Mellone, M1
Melloni, E1
Padoani, G1
Sosti, V1
Vailati, S1
Keywood, C1
Moon, I1
Kang, HG1
Yeo, A1
Noh, H1
Kim, HC1
Song, JS1
Ji, YW1
Lee, HK1
Ogawa, M1
Nagata, T2
Kawakita, T2
Liao, PL1
Huang, SH1
Hung, CH1
Huang, WK1
Tsai, CH1
Kang, JJ1
Wang, HP1
Cheng, YW1
Fu, R2
Jiang, Y1
Zhou, J1
Sun, CW1
Yang, J1
Kleschyov, AL1
Zhuge, Z1
Carlström, M1
Pernow, J1
Wajih, N1
Isbell, TS1
Oh, JY1
Cabrales, P1
Tsai, AG1
Townes, T1
Kim-Shapiro, DB1
Patel, RP1
Lundberg, JO1
Fujimoto, A1
Uraoka, T1
Yahagi, N1
Zafar, MA1
Hammond, AJ1
Hamaguchi, S1
Kono, M1
Zhao, L1
Weiser, JN1
Zhu, M1
Qin, B1
Gu, J1
Tu, Y1
Chen, J1
Liu, D1
Shi, Y1
Liu, X1
Sang, A1
Ding, D1
Cassis, P1
Locatelli, M1
Corna, D1
Villa, S1
Rottoli, D1
Cerullo, D1
Abbate, M1
Remuzzi, G1
Benigni, A1
Zoja, C1
Massud, I1
Cong, ME1
Ruone, S1
Holder, A1
Dinh, C1
Nishiura, K1
Khalil, G1
Pan, Y1
Lipscomb, J1
Johnson, R1
Deyounks, F1
Rooney, JF1
Park, Y1
McCallister, S1
Callebaut, C1
Heneine, W1
García-Lerma, JG1
Kimura, K1
Morita, Y1
Orita, T1
Haruta, J1
Takeji, Y1
Sonoda, KH1
Morsali, D1
Bechtold, D1
Lee, W1
Chauhdry, S1
Palchaudhuri, U1
Hassoon, P1
Snell, DM1
Malpass, K1
Piers, T1
Pocock, J1
Roach, A1
Smith, KJ1
Ueta, M1
Choi, HS1
Lim, JY1
Chun, HJ1
Lee, M1
Kim, ES1
Keum, B1
Seo, YS1
Jeen, YT1
Um, SH1
Lee, HS1
Kim, CD2
Ryu, HS1
Sul, D1
Raz, V1
Sterrenburg, E1
Routledge, S1
Venema, A1
van der Sluijs, BM1
Trollet, C1
Dickson, G1
van Engelen, BG1
van der Maarel, SM1
Antoniou, MN1
Marxreiter, F1
Ettle, B1
May, VE1
Esmer, H1
Patrick, C1
Kragh, CL1
Klucken, J1
Winner, B1
Riess, O1
Winkler, J1
Masliah, E2
Nuber, S1
Paban, V1
Manrique, C1
Filali, M1
Maunoir-Regimbal, S1
Fauvelle, F1
Alescio-Lautier, B1
Kennedy, KM1
Scarbrough, PM1
Ribeiro, A1
Richardson, R1
Yuan, H1
Sonveaux, P1
Landon, CD1
Chi, JT1
Pizzo, S1
Schroeder, T1
Dewhirst, MW1
Ohguchi, T1
Ibrahim, OM1
Shirasawa, T1
Satake, Y1
Ishida, S1
Funahashi, Y2
Yoshida, M2
Yamamoto, T2
Majima, T2
Takai, S2
Gotoh, M2
Lycke, S1
Palm, F1
Østergaard, JA1
Bibby, BM1
Nørregaard, R2
Flyvbjerg, A1
Pedersen, M1
Ardenkjaer-Larsen, JH1
Beggiato, S1
Giuliani, A1
Sivilia, S1
Lorenzini, L1
Antonelli, T1
Imbimbo, BP2
Giardino, L1
Calzà, L1
Ferraro, L1
Yang, H1
Wang, G1
Sun, H1
Shu, R1
Liu, T1
Wang, CE1
Liu, Z1
Zhao, B1
Ouyang, Z1
Huang, J1
Zhou, Y1
Jiang, X1
Xiao, Z1
Li, XJ1
Lai, L1
Nakashima, T3
Sako, N1
Matsuda, T1
Uematsu, N2
Sakurai, K4
Ishida, T1
Savolainen, MH1
Richie, CT1
Harvey, BK1
Männistö, PT1
Maguire-Zeiss, KA1
Arakaki, R2
Eguchi, H1
Yamada, A1
Kudo, Y1
Iwasa, A1
Enkhmaa, T1
Hotta, F1
Mitamura-Aizawa, S1
Mitamura, Y1
Hayashi, Y2
Ishimaru, N2
Fowler, SW1
Chiang, AC1
Savjani, RR1
Larson, ME1
Sherman, MA1
Schuler, DR1
Cirrito, JR1
Lesné, SE1
Jankowsky, JL1
Messmer, EM1
Pathuri, G1
Madka, V1
Hedrick, AF1
Lightfoot, SA1
Awasthi, V1
Cowley, BD1
Rao, CV1
Gali, H1
Rodionov, RN1
Martens-Lobenhoffer, J1
Brilloff, S1
Hohenstein, B1
Jarzebska, N1
Jabs, N1
Kittel, A1
Maas, R1
Weiss, N1
Bode-Böger, SM1
Barada, K1
Mourad, FH2
Noutsi, B1
Saadé, NE2
Park, KD1
Yang, XF1
Dustrude, ET1
Ripsch, MS1
White, FA1
Khanna, R1
Kohn, H1
Takeuchi, K2
Takayama, S1
Hashimoto, E1
Itayama, M1
Amagase, K1
Izuhara, C1
Tsukamoto, H1
Mizoshita, T1
Katano, T1
Hayashi, N1
Ozeki, K1
Ebi, M1
Shimura, T1
Mori, Y2
Tanida, S1
Kataoka, H1
Tsukamoto, T1
Tatematsu, M1
Joh, T1
Peng, B1
Su, YB1
Li, H1
Han, Y1
Guo, C1
Tian, YM1
Peng, XX1
Kim, HJ1
Kim, JH2
Moon, W1
Park, J1
Park, SJ1
Song, GA1
Han, SH1
Lee, JH1
Owens, GP1
Ritchie, A1
Rossi, A1
Schaller, K1
Wemlinger, S1
Schumann, H1
Shearer, A1
Verkman, AS1
Bennett, JL1
Xu, X1
Ma, W1
Gao, P1
Liang, K1
Li, R2
Kohata, Y1
Nakahara, K1
Tanigawa, T1
Yamagami, H1
Shiba, M1
Watanabe, T1
Tominaga, K1
Fujiwara, Y1
Arakawa, T3
Shibamori, M1
Sato, M1
Sato, A1
Yamamura, Y1
Sasabe, H1
Umehara, K1
Liu, J1
Du, J1
Yang, Y1
Oswald, MC1
West, RJ1
Lloyd-Evans, E1
Sweeney, ST1
Yoshihara, HA1
Bastiaansen, JA1
Berthonneche, C1
Comment, A1
Schwitter, J1
Murakami, I1
Zhang, R1
Kubo, M1
Nagaoka, K1
Eguchi, E1
Ogino, K1
Vien, TN1
Modgil, A1
Abramian, AM1
Jurd, R1
Walker, J1
Brandon, NJ1
Terunuma, M1
Rudolph, U1
Maguire, J1
Davies, PA1
Moss, SJ1
Liu, QQ1
Wang, HL1
Chen, K1
Wang, SB1
Xu, Y1
Ye, Q1
Sun, YW1
Yamasaki, T1
Fujinaga, M1
Kawamura, K1
Furutsuka, K1
Nengaki, N1
Shimoda, Y1
Shiomi, S1
Takei, M1
Hashimoto, H1
Yui, J1
Wakizaka, H1
Hatori, A1
Xie, L1
Kumata, K1
Zhang, MR1
Zakaria, S1
El-Sisi, A1
Taiana, M1
Lombardi, R1
Porretta-Serapiglia, C1
Freschi, M1
Bonanno, S2
Marcuzzo, S2
Caravello, F1
Bendotti, C1
Lauria, G1
Sydow, A1
Hochgräfe, K1
Könen, S1
Cadinu, D1
Matenia, D1
Petrova, O1
Joseph, M1
Dennissen, FJ1
Mandelkow, EM2
Abe, N1
Funato, H1
Hirata, A1
Nakai, M1
Iizuka, M1
Shiraishi, H1
Jobu, K1
Yagi, Y1
Kadota, A1
Ogi, K1
Yokota, J1
Miyamura, M1
Woods, EC1
Nawrocki, KL1
Suárez, JM1
McBride, SM1
Bushey, RT1
Moody, MA1
Nicely, NL1
Haynes, BF1
Alam, SM1
Keir, ST1
Bentley, RC1
Roy Choudhury, K1
Gottlin, EB1
Campa, MJ1
Liao, HX1
Patz, EF1
Bonnard, E1
Poras, H1
Fournié-Zaluski, MC2
Roques, BP2
Nagai, N1
Ito, Y1
Okamoto, N1
Shimomura, Y1
Kratter, IH1
Zahed, H1
Lau, A1
Tsvetkov, AS1
Daub, AC1
Weiberth, KF1
Gu, X2
Saudou, F1
Humbert, S1
Yang, XW2
Osmand, A2
Steffan, JS2
Finkbeiner, S2
Nielsen, PM1
Qi, H1
Mikkelsen, E1
Kristensen, ML1
Stødkilde-Jørgensen, H1
Miki, T1
Zwingman, TA1
Wakamori, M1
Lutz, CM1
Cook, SA1
Hosford, DA1
Herrup, K1
Fletcher, CF1
Frankel, WN1
Letts, VA1
Nagai, K1
Doi, T1
Ohshiro, T1
Sunazuka, T1
Tomoda, H1
Takahashi, T3
Omura, S1
Spilman, P1
Lessard, P1
Sattavat, M1
Bush, C1
Tousseyn, T1
Huang, EJ1
Giles, K1
Golde, T1
Das, P1
Fauq, A1
Prusiner, SB1
Dearmond, SJ2
Nicaise, C1
Prozzi, D1
Viaene, E1
Moreno, C1
Gustot, T1
Quertinmont, E1
Demetter, P1
Suain, V1
Goffin, P1
Devière, J1
Hols, P1
Albers, MJ1
Bok, R1
Chen, AP1
Cunningham, CH1
Zierhut, ML1
Zhang, VY1
Kohler, SJ1
Tropp, J2
Hurd, RE1
Yen, YF2
Nelson, SJ2
Vigneron, DB2
Kurhanewicz, J2
Okamoto, R1
Tsuchiya, K1
Nemoto, Y1
Akiyama, J1
Kanai, T1
Watanabe, M1
Sotiriou, E1
Vassilatis, DK1
Vila, M1
Stefanis, L1
Beirowski, B1
Babetto, E1
Gilley, J1
Mazzola, F1
Conforti, L1
Janeckova, L1
Magni, G1
Ribchester, RR1
Coleman, MP1
Schroeder, A1
Fahrenholz, F1
Schmitt, U1
Vaslin, A1
Puyal, J1
Clarke, PG1
Vail, DM1
Thamm, DH1
Reiser, H1
Ray, AS1
Wolfgang, GH1
Watkins, WJ1
Henne, IN1
Hawkins, MJ1
Kurzman, ID1
Jeraj, R1
Vanderhoek, M1
Plaza, S1
Anderson, C1
Wessel, MA1
Robat, C1
Lawrence, J1
Tumas, DB1
Maciejak, P1
Szyndler, J1
Turzyńska, D1
Sobolewska, A1
Taracha, E1
Skórzewska, A1
Lehner, M1
Bidziński, A1
Hamed, A1
Wisłowska-Stanek, A1
Płaźnik, A1
McFarland, NR1
Fan, Z1
Xu, K1
Schwarzschild, MA1
Feany, MB2
Hyman, BT1
McLean, PJ1
Henley, DB1
May, PC1
Dean, RA1
Siemers, ER1
D'Ambrosi, N1
Finocchi, P1
Apolloni, S1
Cozzolino, M1
Ferri, A1
Padovano, V1
Pietrini, G1
Carrì, MT1
Volonté, C1
Qian, J1
Ren, X1
Zhang, P1
Jones, WK1
Molkentin, JD1
Fan, GC1
Kranias, EG1
Escala, W1
Papapetropoulos, S1
Bradley, WG2
Zhai, RG1
Greiner, ER1
Mishra, R1
Kodali, R1
Thompson, LM1
Wetzel, R1
Graham, DR1
Sidhu, A1
Le Roux, P1
Mayer, D1
King, R1
Spielman, D1
Butts Pauly, K1
Pfefferbaum, A1
Vasanawala, S1
Hurd, R1
Hendrickson, LM1
Zhao-Shea, R1
Pang, X1
Gardner, PD1
Tapper, AR1
Miyoshi, Y1
Hamase, K1
Okamura, T1
Konno, R1
Kasai, N1
Tojo, Y1
Zaitsu, K1
Yang, WW1
Sidman, RL1
Taksir, TV1
Treleaven, CM1
Fidler, JA1
Cheng, SH1
Dodge, JC1
Shihabuddin, LS1
Vargas, MR1
Johnson, DA1
Johnson, JA1
Zucca, I1
Mastropietro, A1
de Rosbo, NK1
Cavalcante, P1
Tartari, S1
Preite, L1
Mantegazza, R1
Bernasconi, P1
Peterson, LW1
Kijek, P1
Mitchell, S1
Hilfinger, J1
Breitenbach, J1
Borysko, K1
Drach, JC1
Kashemirov, BA1
McKenna, CE1
Hu, S1
Balakrishnan, A1
Bok, RA1
Anderton, B1
Larson, PE1
Goga, A1
Szego, ÉM1
Gerhardt, E1
Outeiro, TF1
Kermer, P1
Sauer, SW1
Merle, U1
Opp, S1
Haas, D1
Hoffmann, GF1
Stremmel, W1
das Neves Duarte, JM1
Kulak, A1
Gholam-Razaee, MM1
Cuenod, M1
Gruetter, R1
Do, KQ1
Liang, H1
Ward, WF1
Jang, YC1
Bhattacharya, A1
Bokov, AF1
Jernigan, A1
Richardson, A1
Van Remmen, H1
Lattanzi, R1
Sacerdote, P1
Franchi, S1
Canestrelli, M1
Miele, R1
Barra, D1
Visentin, S1
DeNuccio, C1
Porreca, F1
De Felice, M1
Guida, F1
Luongo, L1
de Novellis, V1
Maione, S1
Negri, L1
Gohil, P1
Thakkar, H1
Gohil, U1
Deshpande, S1
Wang, YJ1
Huang, P1
Ung, A1
Blendy, JA1
Liu-Chen, LY1
Duncan, GE1
Koller, BH1
Moy, SS1
Cotella, D1
Hernandez-Enriquez, B1
Pan, Z1
Leveille, J1
Link, CD1
Oddo, S1
Sesti, F1
D'Onofrio, G1
Panza, F1
Frisardi, V1
Solfrizzi, V1
Paroni, G1
Cascavilla, L1
Seripa, D1
Pilotto, A1
Bajsarowicz, K1
Ahn, M1
Ackerman, L1
Dearmond, BN1
Carlson, G1
Busche, MA1
Henning, HA1
Reichwald, J1
Staufenbiel, M2
Sakmann, B1
Konnerth, A1
Brunetti, O1
Imbrici, P1
Botti, FM1
Pettorossi, VE1
D'Adamo, MC1
Valentino, M1
Zammit, C1
Mora, M1
Gibertini, S1
Di Giovanni, G1
Muscat, R1
Pessia, M1
Xu, ZH1
Yang, Q1
Feng, B1
Liu, SB1
Zhang, N1
Xing, JH1
Li, XQ1
Wu, YM1
Gao, GD1
Zhao, MG1
Saheki, T1
Inoue, K1
Ono, H1
Katsura, N1
Yokogawa, M1
Yoshidumi, Y1
Furuie, S1
Kuroda, E1
Ushikai, M1
Asakawa, A1
Inui, A1
Eto, K1
Kadowaki, T1
Sinasac, DS1
Yamamura, K2
Kobayashi, K3
Imaeda, H1
Fujimoto, T1
Takahashi, K1
Kasumi, E1
Fujiyama, Y2
Andoh, A1
Ohnishi, A1
Osaki, T1
Matahira, Y1
Tsuka, T1
Imagawa, T1
Okamoto, Y1
Minami, S1
Zhang, Y1
Lv, SJ1
Yan, H1
Wang, L1
Liang, GP1
Wan, QX1
Peng, X1
Collins, LV1
Kristian, SA1
Weidenmaier, C1
Faigle, M1
Van Kessel, KP1
Van Strijp, JA1
Götz, F1
Neumeister, B1
Peschel, A1
Hahm, KB1
Song, YJ1
Oh, TY1
Lee, JS1
Surh, YJ1
Kim, YB1
Yoo, BM1
Han, SU1
Nahm, KT1
Kim, MW1
Kim, DY1
Cho, SW1
Geracitano, R1
Paolucci, E1
Prisco, S1
Guatteo, E1
Zona, C2
Longone, P2
Ammassari-Teule, M1
Bernardi, G2
Berretta, N1
Mercuri, NB1
Satoh, J1
Tsujikawa, T1
Bamba, T1
Chung, YH1
Joo, KM1
Kim, MJ1
Cha, CI1
Van Damme, P1
Leyssen, M1
Callewaert, G1
Robberecht, W1
Van Den Bosch, L1
Sun, MK1
Alkon, DL1
Garbuzova-Davis, S1
Willing, AE1
Zigova, T1
Saporta, S1
Justen, EB1
Lane, JC1
Hudson, JE1
Chen, N1
Davis, CD1
Sanberg, PR1
Kuo, JJ1
Schonewille, M1
Siddique, T1
Schults, AN1
Bär, PR1
Anelli, R1
Heckman, CJ1
Kroese, AB1
Turner, BJ1
Lopes, EC1
Cheema, SS1
Pieri, M1
Gaetti, C1
Spalloni, A1
Cavalcanti, S1
Mercuri, N1
Hartemann-Heurtier, A1
Mars, LT1
Bercovici, N1
Desbois, S1
Cambouris, C1
Piaggio, E1
Zappulla, J1
Saoudi, A1
Liblau, RS1
Kirkinezos, IG1
Hernandez, D1
Moraes, CT1
Malaisse, WJ1
Ladriere, L1
Verbruggen, I1
Willem, R1
Mahoney, DJ1
Rodriguez, C1
Devries, M1
Yasuda, N1
Tarnopolsky, MA1
Horwitz, AH1
Ammons, WS1
Bauer, RJ1
Dedrick, R1
Nadell, R1
Williams, RE1
Liu, PS1
Zhang, TP1
Gui, T1
Stafford, DW1
Monahan, PE1
Ashida, K1
Katsura, T1
Saito, H1
Inui, K1
Zheng, C1
Nennesmo, I1
Fadeel, B1
Henter, JI1
Taguchi, T1
Yamashita, E1
Mizutani, T1
Nakajima, H1
Yabuuchi, M1
Asano, N1
Miwa, I1
Lo Bianco, C1
Schneider, BL1
Bauer, M1
Sajadi, A1
Brice, A1
Iwatsubo, T1
Aebischer, P1
Cabin, DE1
Gispert-Sanchez, S1
Murphy, D1
Auburger, G1
Myers, RR1
Nussbaum, RL1
Okayama, M1
Tsubouchi, R1
Nishio, H1
Kato, S1
Mangalam, AK1
Khare, M1
Krco, CJ1
Rodriguez, M1
David, CS1
Frasier, M2
Walzer, M1
McCarthy, L1
Magnuson, D1
Lee, JM1
Haas, C1
Kahle, P1
Wolozin, B2
Poon, HF1
Shreve, N1
Calabrese, V1
Butterfield, DA1
Alexander, JJ1
Zwingmann, C1
Quigg, R1
Sfaello, I1
Baud, O1
Arzimanoglou, A1
Gressens, P1
Hiratsuka, T1
Futagami, S1
Tatsuguchi, A1
Suzuki, K1
Shinji, Y1
Kusunoki, M1
Shinoki, K1
Nishigaki, H1
Fujimori, S1
Wada, K1
Miyake, K1
Gudis, K1
Tsukui, T1
Sakamoto, C1
Nakamura, M1
Matsumoto, T1
Atsuda, K1
Hibi, N1
Matsui, H1
Yamada, H1
Tsuchimoto, K1
Maeda, T1
Nagamoto, H1
Kumakura, T1
Takai, M1
Mori, T1
Fogg, MH1
Kaur, A1
Cho, YG1
Carta, M1
Mameli, M1
Valenzuela, CF1
Uyama, E1
Hino, H1
Araki, K1
Takeya, M1
Uchino, M1
Neugebauer, V1
Li, Z1
Zhou, C1
Gu, B1
Frankel, FR1
Maj, R2
Calabresi, M1
Maestroni, S1
Faravelli, L1
Curatolo, L1
Salvati, P2
Fariello, RG2
Laharie, D1
Ménard, S1
Asencio, C1
Vidal-Martinez, T1
Rullier, A1
Zerbib, F1
Candalh, C1
Mégraud, F2
Heyman, M2
Matysiak-Budnik, T2
Sundaram, U1
Wisel, S1
Coon, S1
Steinhilb, ML1
Dias-Santagata, D1
Mulkearns, EE1
Shulman, JM1
Biernat, J1
Atochin, DN1
Wang, A1
Liu, VW1
Critchlow, JD1
Dantas, AP1
Looft-Wilson, R1
Murata, T1
Salomone, S1
Shin, HK1
Ayata, C1
Moskowitz, MA1
Sessa, WC1
Huang, PL1
Herzig, MC1
Paganetti, P1
Jucker, M1
San Miguel Hernández, A1
Inglada-Galiana, L1
García Iglesias, R1
Alonso Castillejos, N1
Martín Gil, FJ1
Marini, JC1
Erez, A1
Castillo, L1
Nicholas, PC1
Kim, D1
Crews, FT1
Macdonald, JM1
Gookin, JL1
Foster, DM1
Coccaro, MR1
Stauffer, SH1
Kohashi, M1
Kabashi, E1
Agar, JN1
Hong, Y1
Taylor, DM1
Minotti, S1
Figlewicz, DA1
Durham, HD1
Lee, JK1
Shin, JH1
Suh, J1
Choi, IS1
Ryu, KS1
Gwag, BJ1
Tóth, B1
Leonhard-Marek, S1
Hedrich, HJ1
Breves, G1
Takeuchi, Y1
Takahashi, M1
Fuchikami, J1
Galvan, V1
Gorostiza, OF1
Banwait, S1
Ataie, M1
Tang, H1
Bredesen, DE1
Craan, AG1
Vinay, P1
Lemieux, G1
Gougoux, A1
Sidhu, GS1
Narasimharao, KL1
Rani, VU1
Sarkar, AK1
Chakravarti, RN1
Mitra, SK1
Cooke, HJ1
Henning, HJ1
Wood, JD1
Cooke, AR1
Yebras, M1
Salvadó, J1
Arola, L1
Remesar, X1
Segués, T1
Leichus, LS1
Goldhill, JM1
Long, JD1
Percy, WH1
Shaw, RD1
Donovan, V1
Burakoff, R1
Bralet, J1
Marie, C1
Mossiat, C1
Lecomte, JM1
Gros, C1
Schwartz, JC1
Sato, F1
Hagiwara, Y1
Kawase, Y1
McNulty, PH1
Sinusas, AJ1
Shi, CQ1
Dione, D1
Young, LH1
Cline, GC1
Shulman, GI1
Gonzalez, W1
Beslot, F1
Laboulandine, I1
Michel, JB1
Andrikopoulos, S1
Proietto, J1
Wu, G1
Meier, SA1
Knabe, DA1
Zea-Iriarte, WL1
Makiyama, K1
Goto, S1
Murase, K1
Urata, Y1
Sekine, I1
Hara, K1
Kondo, T1
Watanabe, S1
Wang, XE1
Hirose, M1
Yoshizawa, T1
Iwazaki, R1
Oide, H1
Kitamura, T1
Miwa, H1
Miyazaki, A1
Sato, N1
Balteskard, L1
Unneberg, K1
Mjaaland, M1
Sager, G1
Jenssen, TG1
Revhaug, A1
Nonaka, M1
Yoshimine, T1
Kohmura, E1
Wakayama, A1
Yamashita, T1
Hayakawa, T1
Wood, PA1
Hamm, DA1
Chen, PY1
Sanders, PW1
Yoshikawa, T1
Tarnawski, A2
Hong, KW1
Kim, KE1
Rhim, BY1
Lee, WS1
Yamane, T1
Nakatani, H1
Matsumoto, H1
Iwata, Y1
Kikuoka, N1
Klivenyi, P1
Ferrante, RJ1
Matthews, RT1
Bogdanov, MB1
Klein, AM1
Andreassen, OA1
Mueller, G1
Wermer, M1
Kaddurah-Daouk, R1
Pevarello, P1
Varasi, M1
McArthur, RA1
Ogawa, T1
Sugidachi, A1
Naganuma, H1
Asai, F1
Moroni, F1
Cozzi, A1
Peruginelli, F1
Carpenedo, R1
Pellegrini-Giampietro, DE1
Mariotti, R1
Bentivoglio, M1
de Mascarel, A1
Abely, M1
Mayo, K1
Kishimoto, S2
Haruma, K2
Tari, A1
Nakano, M1
Nakagawa, Y1
Campbell, BG1
Wootton, JA1
MacLeod, JN1
Minor, RR1
Yao, FS1
Caserta, MT1
Wyrwicz, AM1
Takagaki, M1
Powell, W1
Sood, A1
Spielvogel, BF1
Hosmane, NS1
Kirihata, M1
Ono, K1
Masunaga, SI1
Kinashi, Y1
Miyatake, SI1
Hashimoto, N1
Barada, KA1
Kafrouni, MI1
Khoury, CI1
Szabo, SS1
Nassar, CF1
Silverdale, MA1
Crossman, AR1
Nordgren, A1
Karlsson, T1
Wiklund, L1
Collins, RC1
Mehta, S1
Keel, JA1
Finnerty, WR1
Feeley, JC1
Johnston, DG1
Alberti, KG1
Cács, C1
Wapnir, RA2
Lifshitz, F2
McBride, WJ1
Aprison, MH1
Kusano, K1
Fujimura, J1
Machino, H1
Shimamoto, T1
Kobayashi, H1
Shimizu, S1
Kajiyama, G1
Yamasaki, K1
Sher, PK1
Zdanowicz, MM1
Teichberg, S1
Spencer, PS1
Roy, DN1
Ludolph, A1
Hugon, J1
Dwivedi, MP1
Schaumburg, HH1
Kliegman, RM1
Snider, GL1
Hayes, JA1
Franzblau, C1
Kagan, HM1
Stone, PS1
Korthy, AL1
Craig, CR1
Hartman, ER1
Cohen, AI1
McDaniel, M1
Orr, H1
van Berkel, TJ1
Koster, JF1
Hülsmann, WC1
Buxton, BH1
Stewart, DA1
Murray-Lyon, IM1
Curzon, G1
Williams, R1
Lubs, H1
Machill, G1
Haufe, U1
Haufe, F1

Clinical Trials (16)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Clinical Outcome of Patients With COVID-19 Pneumonia Treated With Corticosteroids and Colchicine in Colombia[NCT04654416]301 participants (Actual)Observational2020-03-20Completed
Open-label Study to Assess the Safety of REMdesivir-HU as Eligible Novel therapY for Moderate and Severe Covid-19 Patients[NCT04610541]Phase 32,000 participants (Anticipated)Interventional2020-10-12Active, not recruiting
Antiviral Activity and Safety of Remdesivir in Bangladeshi Patients With Severe Coronavirus Disease (COVID-19): An Open Label, Multi-Center, Randomized Controlled Trial[NCT04596839]Phase 260 participants (Actual)Interventional2020-09-04Completed
A Multi Center Randomized Open Label Trial on the Safety and Efficacy of Chloroquine for the Treatment of Hospitalized Adults With Laboratory Confirmed SARS-CoV-2 Infection in Vietnam[NCT04328493]Phase 210 participants (Actual)Interventional2020-04-07Completed
Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections.[NCT04365725]84 participants (Actual)Observational2020-05-05Completed
Pilot Study on Cytokine Filtration in COVID-19 ARDS (CytokCOVID19)[NCT04361526]40 participants (Anticipated)Interventional2020-04-17Recruiting
STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis[NCT05603702]Phase 124 participants (Anticipated)Interventional2023-03-17Recruiting
Longitudinal Assessment of Autonomic and Sensory Nervous System in ALS[NCT05747937]100 participants (Anticipated)Interventional2021-05-15Recruiting
Hyperpolarized 13-C Pyruvate MRI Surveillance of Multiple Cancers[NCT05697406]Phase 1/Phase 225 participants (Anticipated)Interventional2024-02-01Not yet recruiting
A Phase 1 Ascending-dose Study to Assess the Safety and Tolerability and Imaging Potential of Hyperpolarized Pyruvate (13C) Injection in Subjects With Prostate Cancer[NCT01229618]Phase 131 participants (Actual)Interventional2010-10-31Completed
Dietary Supplement N-acetylcysteine (NAC) as a Novel Complementary Medicine to Improve Cognitive Disfunction in Schizophrenia[NCT01885338]Phase 126 participants (Actual)Interventional2013-06-30Completed
Study of the Effect of Glutamine Supplementation on Chemotherapy Induced Toxicities in Breast Cancer Patients- A Prospective, Randomised, Single Blind, Three Arm, Phase Four Prevention Trial[NCT00772824]Phase 423 participants (Actual)Interventional2007-12-31Completed
Sport Therapy for Contrasting the Deterioration of Muscle Oxidative Metabolism in Patients Affected by Amyotrophic Lateral Sclerosis (ALS) - Project ME_E_SLA[NCT02548663]30 participants (Actual)Interventional2014-06-30Completed
Quantifying Fatigue of the Respiratory and Swallowing Musculature in Patients With Amyotrophic Lateral Sclerosis[NCT04468191]0 participants (Actual)Interventional2021-02-10Withdrawn (stopped due to COVID-19 pandemic restrictions for data collection)
The Role of Moderate Aerobic Exercise as Determined by Cardiopulmonary Exercise Testing in ALS[NCT03326622]48 participants (Actual)Interventional2013-07-01Completed
"An Observational, Prospective, Multinational, Multicentre Study Comparing the Effectiveness of Safinamide, Rasagiline and Other Standard Of Care as Add-On Therapy to Levodopa (L-Dopa) in Parkinson's Disease (Pd) Fluctuating Patients"[NCT03994328]1,235 participants (Actual)Observational2019-12-03Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

7 reviews available for alanine and Disease Models, Animal

ArticleYear
The contributions of metabolomics in the discovery of new therapeutic targets in Alzheimer's disease.
    Fundamental & clinical pharmacology, 2021, Volume: 35, Issue:3

    Topics: Alanine; Alzheimer Disease; Animals; Arginine; Aspartic Acid; Biomarkers; Disease Models, Animal; Gl

2021
Development of semagacestat (LY450139), a functional gamma-secretase inhibitor, for the treatment of Alzheimer's disease.
    Expert opinion on pharmacotherapy, 2009, Volume: 10, Issue:10

    Topics: Alanine; Alzheimer Disease; Amyloid Precursor Protein Secretases; Animals; Azepines; Cholinesterase

2009
Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease.
    Expert opinion on drug discovery, 2012, Volume: 7, Issue:1

    Topics: Alanine; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor

2012
Chemoprevention of Helicobacter pylori-associated gastric carcinogenesis in a mouse model: is it possible?
    Journal of biochemistry and molecular biology, 2003, Jan-31, Volume: 36, Issue:1

    Topics: Alanine; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cyto

2003
Safinamide: from molecular targets to a new anti-Parkinson drug.
    Neurology, 2006, Oct-10, Volume: 67, Issue:7 Suppl 2

    Topics: Alanine; Animals; Antiparkinson Agents; Benzylamines; Brain Ischemia; Disease Models, Animal; Gerbil

2006
Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing.
    Digestive diseases and sciences, 1998, Volume: 43, Issue:9 Suppl

    Topics: Alanine; Animals; Anti-Ulcer Agents; Clinical Trials as Topic; Disease Models, Animal; Gastric Mucos

1998
Carbohydrate metabolism in liver disease.
    Clinics in endocrinology and metabolism, 1976, Volume: 5, Issue:3

    Topics: Alanine; Alcoholism; Animals; Blood Glucose; Carbohydrate Metabolism; Disease Models, Animal; Fastin

1976

Other Studies

261 other studies available for alanine and Disease Models, Animal

ArticleYear
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 12-08, Volume: 117, Issue:49

    Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr

2020
Combination Treatment with the Vimentin-Targeting Antibody hzVSF and Tenofovir Suppresses Woodchuck Hepatitis Virus Infection in Woodchucks.
    Cells, 2021, 09-05, Volume: 10, Issue:9

    Topics: Alanine; Animals; Antibodies, Monoclonal, Humanized; Antiviral Agents; Disease Models, Animal; Drug

2021
Remdesivir is efficacious in rhesus monkeys exposed to aerosolized Ebola virus.
    Scientific reports, 2021, 09-30, Volume: 11, Issue:1

    Topics: Adenosine Monophosphate; Administration, Intravenous; Aerosols; Alanine; Animals; Antiviral Agents;

2021
Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19.
    Nature communications, 2021, 10-18, Volume: 12, Issue:1

    Topics: Adenosine Monophosphate; Alanine; Animals; Chlorocebus aethiops; Coronavirus 229E, Human; Coronaviru

2021
Strengthened rebamipide ocular nanoformulation to effectively treat corneal alkali burns in mice through the HMGB1 signaling pathway.
    Experimental eye research, 2021, Volume: 213

    Topics: Alanine; Animals; Antioxidants; Blotting, Western; Burns, Chemical; Chickens; Chorioallantoic Membra

2021
Engineering a Remedy to Modulate and Optimize Biopharmaceutical Properties of Rebamipide by Synthesizing New Cocrystal: In Silico and Experimental Studies.
    Pharmaceutical research, 2021, Volume: 38, Issue:12

    Topics: Alanine; Animals; Biological Availability; Biological Products; Carrageenan; Chemical Engineering; C

2021
Subcutaneous remdesivir administration prevents interstitial pneumonia in rhesus macaques inoculated with SARS-CoV-2.
    Antiviral research, 2022, Volume: 198

    Topics: Adenosine Monophosphate; Administration, Cutaneous; Alanine; Animals; Antiviral Agents; COVID-19 Dru

2022
Metabolomic and transcriptomic signatures of chemogenetic heart failure.
    American journal of physiology. Heart and circulatory physiology, 2022, 03-01, Volume: 322, Issue:3

    Topics: Alanine; Amino Acids; Animals; Cardiomyopathy, Dilated; Dependovirus; Disease Models, Animal; Heart

2022
An Alanine Aminotransferase Is Required for Biofilm-Specific Resistance of Aspergillus fumigatus to Echinocandin Treatment.
    mBio, 2022, 04-26, Volume: 13, Issue:2

    Topics: Alanine; Alanine Transaminase; Animals; Antifungal Agents; Aspergillus fumigatus; Biofilms; Disease

2022
LY450139 Inhibited Ti-Particle-Induced Bone Dissolution via Suppressing Notch and NF-κB Signaling Pathways.
    Calcified tissue international, 2022, Volume: 111, Issue:2

    Topics: Alanine; Animals; Azepines; Bone Resorption; Disease Models, Animal; Mice; Mice, Inbred C57BL; NF-ka

2022
Insights into the development of pentylenetetrazole-induced epileptic seizures from dynamic metabolomic changes.
    Metabolic brain disease, 2022, Volume: 37, Issue:7

    Topics: Alanine; Animals; Anticonvulsants; Asparagine; Citrates; Creatine; Creatinine; Disease Models, Anima

2022
NMR-based metabolomic analysis for the effects of moxibustion on imiquimod-induced psoriatic mice.
    Journal of ethnopharmacology, 2023, Jan-10, Volume: 300

    Topics: Alanine; Animals; Asparagine; Aspartic Acid; Cytokines; Disease Models, Animal; Glucose; Histidine;

2023
Metabolic profiles of saliva in male mouse models of chronic sleep disorders induced by psychophysiological stress.
    Scientific reports, 2023, 07-10, Volume: 13, Issue:1

    Topics: Alanine; Animals; Chronic Disease; Disease Models, Animal; Fabaceae; Male; Metabolome; Mice; Psychop

2023
Immune modulation by rebamipide in a mouse model of Sjogren's syndrome via T and B cell regulation.
    Immunology letters, 2019, Volume: 214

    Topics: Alanine; Animals; B-Lymphocytes, Regulatory; Cytokines; Disease Models, Animal; Immunomodulation; Mi

2019
Correlation among body composition and metabolic regulation in a male mouse model of Cushing's syndrome.
    Endocrine journal, 2020, Jan-28, Volume: 67, Issue:1

    Topics: Adipocytes, White; Adipose Tissue; Adipose Tissue, White; Adrenal Cortex Hormones; Alanine; Alanine

2020
Graft Versus Host Disease-Associated Dry Eye: Role of Ocular Surface Mucins and the Effect of Rebamipide, a Mucin Secretagogue.
    Investigative ophthalmology & visual science, 2019, 11-01, Volume: 60, Issue:14

    Topics: Administration, Ophthalmic; Alanine; Animals; Antioxidants; Bone Marrow Transplantation; CA-125 Anti

2019
Behavioural and dopaminergic changes in double mutated human A30P*A53T alpha-synuclein transgenic mouse model of Parkinson´s disease.
    Scientific reports, 2019, 11-22, Volume: 9, Issue:1

    Topics: Aging; Alanine; alpha-Synuclein; Amino Acid Substitution; Animals; Behavior, Animal; Disease Models,

2019
TAF and TDF attenuate liver fibrosis through NS5ATP9, TGFβ1/Smad3, and NF-κB/NLRP3 inflammasome signaling pathways.
    Hepatology international, 2020, Volume: 14, Issue:1

    Topics: Adenine; Alanine; Animals; Antiviral Agents; Carbon Tetrachloride; Disease Models, Animal; DNA-Bindi

2020
Rebamipide promotes lacrimal duct epithelial cell survival via protecting barrier function.
    Scientific reports, 2020, 02-03, Volume: 10, Issue:1

    Topics: Alanine; Animals; Anti-Ulcer Agents; Cell Survival; Cells, Cultured; Disease Models, Animal; Electri

2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections

2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections

2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections

2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections

2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections

2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections

2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections

2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections

2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections

2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections

2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections

2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections

2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections

2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections

2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections

2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections

2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections

2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections

2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections

2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections

2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections

2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections

2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections

2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections

2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections

2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections

2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections

2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections

2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections

2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections

2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections

2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections

2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections

2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections

2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections

2020
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection.
    Proceedings of the National Academy of Sciences of the United States of America, 2020, 03-24, Volume: 117, Issue:12

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections

2020
More than 80 clinical trials launch to test coronavirus treatments.
    Nature, 2020, Volume: 578, Issue:7795

    Topics: Adenosine Monophosphate; Alanine; Animals; Anti-HIV Agents; Betacoronavirus; China; Chloroquine; Cli

2020
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice.
    Science translational medicine, 2020, 04-29, Volume: 12, Issue:541

    Topics: Adenosine Monophosphate; Alanine; Animals; Antibiotic Prophylaxis; Antiviral Agents; Betacoronavirus

2020
Novel Mutant Phospholipase D from
    Molecules (Basel, Switzerland), 2020, Apr-04, Volume: 25, Issue:7

    Topics: Alanine; Amino Acid Substitution; Animals; Arthropod Proteins; Disease Models, Animal; Histidine; Im

2020
Unblending of Transcriptional Condensates in Human Repeat Expansion Disease.
    Cell, 2020, 05-28, Volume: 181, Issue:5

    Topics: Alanine; Animals; Base Sequence; Disease Models, Animal; DNA Repeat Expansion; Homeodomain Proteins;

2020
Remdesivir (GS-5734) Is Efficacious in Cynomolgus Macaques Infected With Marburg Virus.
    The Journal of infectious diseases, 2020, 11-09, Volume: 222, Issue:11

    Topics: Adenosine Monophosphate; Alanine; Animals; Antimetabolites; Antiviral Agents; Disease Models, Animal

2020
Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2.
    Nature, 2020, Volume: 585, Issue:7824

    Topics: Adenosine Monophosphate; Alanine; Animals; Betacoronavirus; Bronchoalveolar Lavage Fluid; Coronaviru

2020
Mouse-adapted SARS-CoV-2 replicates efficiently in the upper and lower respiratory tract of BALB/c and C57BL/6J mice.
    Protein & cell, 2020, Volume: 11, Issue:10

    Topics: Adaptation, Physiological; Adenosine Monophosphate; Administration, Intranasal; Alanine; Animals; Be

2020
Hepatoprotective effect of rebamipide against methotrexate-induced hepatic intoxication: role of Nrf2/GSK-3β, NF-κβ-p65/JAK1/STAT3, and PUMA/Bax/Bcl-2 signaling pathways.
    Immunopharmacology and immunotoxicology, 2020, Volume: 42, Issue:5

    Topics: Alanine; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins;

2020
Quantifying the effect of remdesivir in rhesus macaques infected with SARS-CoV-2.
    Virology, 2020, Volume: 550

    Topics: Adenosine Monophosphate; Alanine; Animals; Antiviral Agents; Betacoronavirus; Coronavirus Infections

2020
Pharmacological antagonism of kainate receptor rescues dysfunction and loss of dopamine neurons in a mouse model of human parkin-induced toxicity.
    Cell death & disease, 2020, 11-10, Volume: 11, Issue:11

    Topics: Alanine; Animals; Disease Models, Animal; Dopaminergic Neurons; Down-Regulation; Female; GluK2 Kaina

2020
Protective effect and mechanism of rebamipide on NSAIDs associated small bowel injury.
    International immunopharmacology, 2021, Volume: 90

    Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Claudin-1; Cytokines; Diclofenac; Disease

2021
Available drugs and supplements for rapid deployment for treatment of COVID-19.
    Journal of molecular cell biology, 2021, 07-06, Volume: 13, Issue:3

    Topics: Adenosine Monophosphate; Alanine; Animals; COVID-19; COVID-19 Drug Treatment; Disease Models, Animal

2021
Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infection.
    Emerging microbes & infections, 2021, Volume: 10, Issue:1

    Topics: Adenosine Monophosphate; Alanine; Animals; Antibodies, Viral; Antiviral Agents; COVID-19; COVID-19 D

2021
Liver alanine catabolism promotes skeletal muscle atrophy and hyperglycaemia in type 2 diabetes.
    Nature metabolism, 2021, Volume: 3, Issue:3

    Topics: Alanine; Alanine Transaminase; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Disease Models, An

2021
Combination therapy protects macaques against advanced Marburg virus disease.
    Nature communications, 2021, 03-25, Volume: 12, Issue:1

    Topics: Adenosine Monophosphate; Alanine; Animals; Antibodies, Monoclonal; Antibodies, Viral; Disease Models

2021
Isotope tracing in adult zebrafish reveals alanine cycling between melanoma and liver.
    Cell metabolism, 2021, 07-06, Volume: 33, Issue:7

    Topics: Aging; Alanine; Animals; Animals, Genetically Modified; Cell Tracking; Disease Models, Animal; Gluco

2021
Remdesivir Alleviates Acute Kidney Injury by Inhibiting the Activation of NLRP3 Inflammasome.
    Frontiers in immunology, 2021, Volume: 12

    Topics: Acute Kidney Injury; Adenosine Monophosphate; Alanine; Animals; Anti-Inflammatory Agents; Cells, Cul

2021
Brivanib alaninate inhibited dengue virus proliferation through VEGFR2/AMPK pathway.
    Pharmacological research, 2021, Volume: 170

    Topics: Alanine; AMP-Activated Protein Kinases; Animals; Antiviral Agents; Cells, Cultured; Dengue; Dengue V

2021
Hyperpolarized pyruvate to measure the influence of PKM2 activation on glucose metabolism in the healthy kidney.
    NMR in biomedicine, 2021, Volume: 34, Issue:11

    Topics: Alanine; Animals; Bicarbonates; Disease Models, Animal; Enzyme Activation; Glucose; Glycolysis; Hema

2021
BCAAs and Di-Alanine supplementation in the prevention of skeletal muscle atrophy: preclinical evaluation in a murine model of hind limb unloading.
    Pharmacological research, 2021, Volume: 171

    Topics: Alanine; Amino Acids, Branched-Chain; Animals; Dipeptides; Disease Models, Animal; Hindlimb Suspensi

2021
Post Stroke Safinamide Treatment Attenuates Neurological Damage by Modulating Autophagy and Apoptosis in Experimental Model of Stroke in Rats.
    Molecular neurobiology, 2021, Volume: 58, Issue:12

    Topics: Alanine; Animals; Apoptosis; Autophagy; Benzylamines; Brain; Cytokines; Disease Models, Animal; Infa

2021
Disruption of GluA2 phosphorylation potentiates stress responsivity.
    Behavioural brain research, 2017, 08-30, Volume: 333

    Topics: Alanine; Animals; Cocaine; Conditioning, Operant; Disease Models, Animal; Dopamine Uptake Inhibitors

2017
Development and Properties of Valine-Alanine based Antibody-Drug Conjugates with Monomethyl Auristatin E as the Potent Payload.
    International journal of molecular sciences, 2017, Aug-25, Volume: 18, Issue:9

    Topics: Alanine; Animals; Antibodies, Monoclonal; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Di

2017
Semagacestat Is a Pseudo-Inhibitor of γ-Secretase.
    Cell reports, 2017, Oct-03, Volume: 21, Issue:1

    Topics: Alanine; Alzheimer Disease; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; An

2017
Nuclear localized C9orf72-associated arginine-containing dipeptides exhibit age-dependent toxicity in C. elegans.
    Human molecular genetics, 2017, 12-15, Volume: 26, Issue:24

    Topics: Age Factors; Alanine; Amyotrophic Lateral Sclerosis; Animals; Arginine; C9orf72 Protein; Caenorhabdi

2017
Rebamipide alleviates radiation-induced colitis through improvement of goblet cell differentiation in mice.
    Journal of gastroenterology and hepatology, 2018, Volume: 33, Issue:4

    Topics: Alanine; Animals; Anti-Ulcer Agents; Cell Differentiation; Cell Proliferation; Colitis; Colon; Disea

2018
Additive Effects of Rebamipide Plus Proton Pump Inhibitors on the Expression of Tight Junction Proteins in a Rat Model of Gastro-Esophageal Reflux Disease.
    Gut and liver, 2018, Jan-15, Volume: 12, Issue:1

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Alanine; Animals; Anti-Ulcer Agents; Disease Models, Animal

2018
Gamma-Secretase Inhibitors Attenuate Neurotrauma and Neurogenic Acute Lung Injury in Rats by Rescuing the Accumulation of Hypertrophic Microglia.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2017, Volume: 44, Issue:5

    Topics: Acute Lung Injury; Alanine; Amyloid Precursor Protein Secretases; Animals; Azepines; Blood-Brain Bar

2017
A D-Alanine auxotrophic live vaccine is effective against lethal infection caused by Staphylococcus aureus.
    Virulence, 2018, 01-01, Volume: 9, Issue:1

    Topics: Alanine; Animals; Antibodies, Bacterial; Bacteremia; Cells, Cultured; Cross Reactions; Disease Model

2018
[Development of "Patient Friendly Formulations" to Counter the Side Effects of Cancer Chemotherapy].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2018, Volume: 138, Issue:2

    Topics: Administration, Oral; Alanine; Animals; Antineoplastic Agents; Cell Communication; Cyclic AMP; Disea

2018
Effects of Ginkgo Biloba Extract on A53T α-Synuclein Transgenic Mouse Models of Parkinson's Disease.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2018, Volume: 45, Issue:2

    Topics: Alanine; alpha-Synuclein; Animals; Antiparkinson Agents; Disease Models, Animal; Dopamine Plasma Mem

2018
The Role of 2% Rebamipide Eye Drops Related to Conjunctival Differentiation in Superoxide Dismutase-1 (Sod1) Knockout Mice.
    Investigative ophthalmology & visual science, 2018, 03-01, Volume: 59, Issue:3

    Topics: Alanine; Animals; Antioxidants; Biomarkers; Cell Differentiation; Conjunctiva; Disease Models, Anima

2018
Rewiring of Glutamine Metabolism Is a Bioenergetic Adaptation of Human Cells with Mitochondrial DNA Mutations.
    Cell metabolism, 2018, May-01, Volume: 27, Issue:5

    Topics: Adaptation, Physiological; Alanine; Animals; Disease Models, Animal; DNA, Mitochondrial; Energy Meta

2018
Zebrafish, a Novel Model System to Study Uremic Toxins: The Case for the Sulfur Amino Acid Lanthionine.
    International journal of molecular sciences, 2018, Apr-29, Volume: 19, Issue:5

    Topics: Alanine; Animals; Disease Models, Animal; Organogenesis; Sulfides; Toxins, Biological; Uremia; Xenob

2018
The Role of Kainate Receptors in the Pathophysiology of Hypoxia-Induced Seizures in the Neonatal Mouse.
    Scientific reports, 2018, 05-04, Volume: 8, Issue:1

    Topics: Alanine; Animals; Animals, Newborn; Disease Models, Animal; Disease Susceptibility; Electroencephalo

2018
A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson's disease-like pathology in neurons and glia.
    Acta neuropathologica communications, 2018, 05-10, Volume: 6, Issue:1

    Topics: Alanine; alpha-Synuclein; Animals; Calcium-Binding Proteins; Disease Models, Animal; Endopeptidase K

2018
M10, a novel derivative of Myricetin, prevents ulcerative colitis and colorectal tumor through attenuating robust endoplasmic reticulum stress.
    Carcinogenesis, 2018, 07-03, Volume: 39, Issue:7

    Topics: Alanine; Animals; Anticarcinogenic Agents; Colitis, Ulcerative; Colon; Colorectal Neoplasms; Disease

2018
Suppression of Postprandial Blood Glucose Fluctuations by a Low-Carbohydrate, High-Protein, and High-Omega-3 Diet via Inhibition of Gluconeogenesis.
    International journal of molecular sciences, 2018, Jun-21, Volume: 19, Issue:7

    Topics: Alanine; Alanine Transaminase; Animals; Blood Glucose; Carbon Isotopes; Diabetes Mellitus, Experimen

2018
Cold Storage Injury to Rat Small-bowel Transplants-Beneficial Effect of a Modified HTK Solution.
    Transplantation, 2018, Volume: 102, Issue:10

    Topics: Alanine; Animals; Cell Hypoxia; Cold Ischemia; Disease Models, Animal; Glucose; Glycine; Humans; Int

2018
Metabolic Response in Rabbit Urine to Occurrence and Relief of Unilateral Ureteral Obstruction.
    Journal of proteome research, 2018, 09-07, Volume: 17, Issue:9

    Topics: Acetic Acid; Alanine; Analysis of Variance; Animals; Biomarkers; Citric Acid; Creatinine; Disease Mo

2018
Evaluation of the accuracy of exchangeable copper and relative exchangeable copper (REC) in a mouse model of Wilson's disease.
    Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS), 2018, Volume: 50

    Topics: Adenosine Triphosphatases; Alanine; Animals; Aspartate Aminotransferases; Bilirubin; Biomarkers; Cop

2018
Safinamide Modulates Striatal Glutamatergic Signaling in a Rat Model of Levodopa-Induced Dyskinesia.
    The Journal of pharmacology and experimental therapeutics, 2018, Volume: 367, Issue:3

    Topics: Alanine; Animals; Antiparkinson Agents; Benzylamines; Corpus Striatum; Disease Models, Animal; Dopam

2018
Comparison of Ocular Surface Mucin Expression After Topical Ophthalmic Drug Administration in Dry Eye-Induced Mouse Model.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2018, Volume: 34, Issue:9

    Topics: Administration, Topical; Alanine; Animals; Anti-Inflammatory Agents; Cyclosporine; Disease Models, A

2018
The Effect of Rebamipide Ophthalmic Solution on Cytokine and Mucin Secretion in Culture of Conjunctival Epithelial Cells From the Cu, Zn-Superoxide Dismutase-1 (SOD-1) Knock-Down Mouse.
    Eye & contact lens, 2019, Volume: 45, Issue:2

    Topics: Alanine; Animals; Antioxidants; Cells, Cultured; Conjunctiva; Conjunctival Diseases; Copper; Cytokin

2019
Efficacy of Azatyrosine-Phenylbutyric Hydroxamides, a Histone Deacetylase Inhibitor, on Chemotherapy-Induced Gastrointestinal Mucositis.
    International journal of molecular sciences, 2019, Jan-10, Volume: 20, Issue:2

    Topics: Alanine; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Disease Models, Animal; Gene Expr

2019
Rebamipide ophthalmic solution modulates the ratio of T helper cell 17/regulatory T cells in dry eye disease mice.
    Molecular medicine reports, 2019, Volume: 19, Issue:5

    Topics: Alanine; Animals; Conjunctiva; Cornea; Cytokines; Disease Models, Animal; Dry Eye Syndromes; Female;

2019
Hemoglobin β93 Cysteine Is Not Required for Export of Nitric Oxide Bioactivity From the Red Blood Cell.
    Circulation, 2019, 06-04, Volume: 139, Issue:23

    Topics: Alanine; Amino Acid Substitution; Animals; beta-Globins; Biological Transport; Blood Platelets; Cyst

2019
Rebamipide solution as a submucosal injection material for possible prevention of gastric stenosis after endoscopic submucosal dissection.
    Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society, 2019, Volume: 31 Suppl 1

    Topics: Alanine; Animals; Anti-Ulcer Agents; Disease Models, Animal; Endoscopic Mucosal Resection; Gastric M

2019
Identification of Pneumococcal Factors Affecting Pneumococcal Shedding Shows that the
    mBio, 2019, 06-18, Volume: 10, Issue:3

    Topics: Alanine; Animals; Animals, Newborn; Bacterial Proteins; Bacterial Shedding; Disease Models, Animal;

2019
Brivanib, a multitargeted small-molecule tyrosine kinase inhibitor, suppresses laser-induced CNV in a mouse model of neovascular AMD.
    Journal of cellular physiology, 2020, Volume: 235, Issue:2

    Topics: Alanine; Angiogenesis Inhibitors; Animals; Cell Movement; Cell Proliferation; Choroidal Neovasculari

2020
Addition of cyclic angiotensin-(1-7) to angiotensin-converting enzyme inhibitor therapy has a positive add-on effect in experimental diabetic nephropathy.
    Kidney international, 2019, Volume: 96, Issue:4

    Topics: Alanine; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Type 2

2019
Efficacy of Oral Tenofovir Alafenamide/Emtricitabine Combination or Single-Agent Tenofovir Alafenamide Against Vaginal Simian Human Immunodeficiency Virus Infection in Macaques.
    The Journal of infectious diseases, 2019, 10-22, Volume: 220, Issue:11

    Topics: Adenine; Alanine; Animals; Anti-HIV Agents; Chemoprevention; Disease Models, Animal; Disease Transmi

2019
Protection of human corneal epithelial cells from TNF-α-induced disruption of barrier function by rebamipide.
    Investigative ophthalmology & visual science, 2013, Apr-17, Volume: 54, Issue:4

    Topics: Adherens Junctions; Alanine; Animals; Antioxidants; beta Catenin; Cadherins; Cell Line; Disease Mode

2013
Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis.
    Brain : a journal of neurology, 2013, Volume: 136, Issue:Pt 4

    Topics: Alanine; Animals; Benzylamines; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental;

2013
Rebamipide suppresses PolyI:C-stimulated cytokine production in human conjunctival epithelial cells.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2013, Volume: 29, Issue:7

    Topics: Alanine; Animals; Antioxidants; Conjunctiva; Conjunctivitis, Allergic; Cytokines; Disease Models, An

2013
The effect of polaprezinc on gastric mucosal protection in rats with ethanol-induced gastric mucosal damage: comparison study with rebamipide.
    Life sciences, 2013, Jul-30, Volume: 93, Issue:2-3

    Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antioxidants; Carnosin

2013
Nuclear entrapment and extracellular depletion of PCOLCE is associated with muscle degeneration in oculopharyngeal muscular dystrophy.
    BMC neurology, 2013, Jul-01, Volume: 13

    Topics: Age Factors; Alanine; Animals; Cell Nucleolus; Cells, Cultured; Collagen; Disease Models, Animal; Do

2013
Glial A30P alpha-synuclein pathology segregates neurogenesis from anxiety-related behavior in conditional transgenic mice.
    Neurobiology of disease, 2013, Volume: 59

    Topics: Alanine; alpha-Synuclein; Animals; Anxiety; Avoidance Learning; Cell Count; Disease Models, Animal;

2013
Therapeutic and preventive effects of methylene blue on Alzheimer's disease pathology in a transgenic mouse model.
    Neuropharmacology, 2014, Volume: 76 Pt A

    Topics: Administration, Oral; Alanine; Alzheimer Disease; Amyloid beta-Peptides; Animals; Avoidance Learning

2014
Catabolism of exogenous lactate reveals it as a legitimate metabolic substrate in breast cancer.
    PloS one, 2013, Volume: 8, Issue:9

    Topics: Adult; Aged; Alanine; Animals; Breast Neoplasms; Cell Death; Cell Hypoxia; Cell Line, Tumor; Coumari

2013
The effects of 2% rebamipide ophthalmic solution on the tear functions and ocular surface of the superoxide dismutase-1 (sod1) knockout mice.
    Investigative ophthalmology & visual science, 2013, Nov-21, Volume: 54, Issue:12

    Topics: Alanine; Animals; Conjunctiva; Disease Models, Animal; Dose-Response Relationship, Drug; Dry Eye Syn

2013
Intravesical application of rebamipide suppresses bladder inflammation in a rat cystitis model.
    The Journal of urology, 2014, Volume: 191, Issue:4

    Topics: Administration, Intravesical; Alanine; Animals; Cystitis; Disease Models, Animal; Female; Quinolones

2014
High altitude may alter oxygen availability and renal metabolism in diabetics as measured by hyperpolarized [1-(13)C]pyruvate magnetic resonance imaging.
    Kidney international, 2014, Volume: 86, Issue:1

    Topics: Alanine; Altitude; Altitude Sickness; Animals; Atmospheric Pressure; Bicarbonates; Blood Glucose; Di

2014
CHF5074 and LY450139 sub-acute treatments differently affect cortical extracellular glutamate levels in pre-plaque Tg2576 mice.
    Neuroscience, 2014, Apr-25, Volume: 266

    Topics: Alanine; Alzheimer Disease; Animals; Azepines; Cyclopropanes; Disease Models, Animal; Extracellular

2014
Species-dependent neuropathology in transgenic SOD1 pigs.
    Cell research, 2014, Volume: 24, Issue:4

    Topics: Alanine; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Animals; Animals, Genetically Modif

2014
Novel submicronized rebamipide liquid with moderate viscosity: significant effects on oral mucositis in animal models.
    Biological & pharmaceutical bulletin, 2014, Volume: 37, Issue:4

    Topics: Administration, Oral; Alanine; Animals; Anti-Ulcer Agents; Cautery; Disease Models, Animal; Drug Car

2014
The beneficial effect of a prolyl oligopeptidase inhibitor, KYP-2047, on alpha-synuclein clearance and autophagy in A30P transgenic mouse.
    Neurobiology of disease, 2014, Volume: 68

    Topics: Alanine; alpha-Synuclein; Animals; Autophagy; Brain; Brain Diseases; Cell Line, Transformed; Disease

2014
Anti-inflammatory effects of rebamipide eyedrop administration on ocular lesions in a murine model of primary Sjögren's syndrome.
    PloS one, 2014, Volume: 9, Issue:5

    Topics: Administration, Ophthalmic; Alanine; Animals; Anti-Inflammatory Agents; Cells, Cultured; Disease Mod

2014
Genetic modulation of soluble Aβ rescues cognitive and synaptic impairment in a mouse model of Alzheimer's disease.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2014, Jun-04, Volume: 34, Issue:23

    Topics: Alanine; Alzheimer Disease; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; An

2014
[New therapeutic options for dry eye].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2014, Volume: 111, Issue:5

    Topics: Alanine; Animals; Anti-Ulcer Agents; Cornea; Disease Models, Animal; Dry Eye Syndromes; Female; Huma

2014
Evaluation of (99m)Tc-probestin SPECT as a novel technique for noninvasive imaging of kidney aminopeptidase N expression.
    Molecular pharmaceutics, 2014, Aug-04, Volume: 11, Issue:8

    Topics: Alanine; Animals; CD13 Antigens; Disease Models, Animal; Female; Genotype; Immunohistochemistry; Kid

2014
Intravesical application of rebamipide promotes urothelial healing in a rat cystitis model.
    The Journal of urology, 2014, Volume: 192, Issue:6

    Topics: Administration, Intravesical; Alanine; Animals; Cystitis; Disease Models, Animal; Female; Quinolones

2014
Role of alanine:glyoxylate aminotransferase 2 in metabolism of asymmetric dimethylarginine in the settings of asymmetric dimethylarginine overload and bilateral nephrectomy.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2014, Volume: 29, Issue:11

    Topics: Acute Kidney Injury; Alanine; Animals; Arginine; Biomarkers; Blotting, Western; Disease Models, Anim

2014
Electrocautery-induced localized colonic injury elicits increased levels of pro-inflammatory cytokines in small bowel and decreases jejunal alanine absorption.
    Cytokine, 2015, Volume: 71, Issue:1

    Topics: Alanine; Animals; Colitis; Colon; Cytokines; Disease Models, Animal; Duodenum; Electrocoagulation; I

2015
Chimeric agents derived from the functionalized amino acid, lacosamide, and the α-aminoamide, safinamide: evaluation of their inhibitory actions on voltage-gated sodium channels, and antiseizure and antinociception activities and comparison with lacosamid
    ACS chemical neuroscience, 2015, Feb-18, Volume: 6, Issue:2

    Topics: Acetamides; Alanine; Analgesics; Animals; Anticonvulsants; Benzylamines; Cells, Cultured; Cerebral C

2015
Effect of rebamipide on gastric bleeding and ulcerogenic responses induced by aspirin plus clopidogrel under stimulation of acid secretion in rats.
    Journal of gastroenterology and hepatology, 2014, Volume: 29 Suppl 4

    Topics: Alanine; Animals; Anti-Ulcer Agents; Aspirin; Clopidogrel; Disease Models, Animal; Gastric Acid; Gas

2014
Preventive effect of rebamipide on N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats.
    Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie, 2015, Volume: 67, Issue:3

    Topics: Adenocarcinoma; Alanine; Animals; Antioxidants; Carcinogenesis; Carcinogens; Disease Models, Animal;

2015
Exogenous alanine and/or glucose plus kanamycin kills antibiotic-resistant bacteria.
    Cell metabolism, 2015, Feb-03, Volume: 21, Issue:2

    Topics: Alanine; Animals; Anti-Bacterial Agents; Bacteria; Disease Models, Animal; Dose-Response Relationshi

2015
Rebamipide attenuates 5-Fluorouracil-induced small intestinal mucositis in a mouse model.
    Biological & pharmaceutical bulletin, 2015, Volume: 38, Issue:2

    Topics: Alanine; Animals; Anti-Ulcer Agents; Antimetabolites, Antineoplastic; Apoptosis; Disease Models, Ani

2015
Mutagenesis of the aquaporin 4 extracellular domains defines restricted binding patterns of pathogenic neuromyelitis optica IgG.
    The Journal of biological chemistry, 2015, May-08, Volume: 290, Issue:19

    Topics: Alanine; Animals; Antibodies, Monoclonal; Aquaporin 4; Autoantibodies; Cell Separation; CHO Cells; C

2015
Rebamipide suppresses TNF-α mediated inflammation in vitro and attenuates the severity of dermatitis in mice.
    The FEBS journal, 2015, Volume: 282, Issue:12

    Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line, Transformed; Dermatitis, Aller

2015
Rebamipide Alters the Esophageal Microbiome and Reduces the Incidence of Barrett's Esophagus in a Rat Model.
    Digestive diseases and sciences, 2015, Volume: 60, Issue:9

    Topics: Alanine; Animals; Anti-Ulcer Agents; Barrett Esophagus; Clostridium; Disease Models, Animal; Enteroc

2015
Rebamipide does not interfere with the antitumor effect of radiotherapy or chemotherapy in human oral tumor-bearing nude mice.
    Journal of pharmacological sciences, 2015, Volume: 129, Issue:1

    Topics: Alanine; Animals; Antineoplastic Agents; Antioxidants; Carcinoma, Squamous Cell; Cell Line, Tumor; C

2015
Phosphorylation of TRPV1 by cyclin-dependent kinase 5 promotes TRPV1 surface localization, leading to inflammatory thermal hyperalgesia.
    Experimental neurology, 2015, Volume: 273

    Topics: Alanine; Animals; Calcium; Cells, Cultured; Cyclin-Dependent Kinase 5; Disease Models, Animal; Freun

2015
Identification of dietary alanine toxicity and trafficking dysfunction in a Drosophila model of hereditary sensory and autonomic neuropathy type 1.
    Human molecular genetics, 2015, Dec-15, Volume: 24, Issue:24

    Topics: Alanine; Animals; Animals, Genetically Modified; Diet; Disease Models, Animal; Drosophila; Endoplasm

2015
An intact small animal model of myocardial ischemia-reperfusion: Characterization of metabolic changes by hyperpolarized 13C MR spectroscopy.
    American journal of physiology. Heart and circulatory physiology, 2015, Dec-15, Volume: 309, Issue:12

    Topics: Alanine; Animals; Bicarbonates; Carbon Isotopes; Disease Models, Animal; Hemodynamics; Inflammation;

2015
Rebamipide suppresses mite-induced asthmatic responses in NC/Nga mice.
    American journal of physiology. Lung cellular and molecular physiology, 2015, Oct-15, Volume: 309, Issue:8

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Alanine; Allergens; Animals; Antigens, Dermatophagoides; Antioxidants;

2015
Compromising the phosphodependent regulation of the GABAAR β3 subunit reproduces the core phenotypes of autism spectrum disorders.
    Proceedings of the National Academy of Sciences of the United States of America, 2015, Dec-01, Volume: 112, Issue:48

    Topics: Alanine; Animals; Autism Spectrum Disorder; Behavior, Animal; Biotinylation; Cell Membrane; Dendriti

2015
Oridonin derivative ameliorates experimental colitis by inhibiting activated T-cells and translocation of nuclear factor-kappa B.
    Journal of digestive diseases, 2016, Volume: 17, Issue:2

    Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Colitis; Colon; Cytokines; Disease Models

2016
Dynamic Changes in Striatal mGluR1 But Not mGluR5 during Pathological Progression of Parkinson's Disease in Human Alpha-Synuclein A53T Transgenic Rats: A Multi-PET Imaging Study.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2016, Jan-13, Volume: 36, Issue:2

    Topics: Alanine; alpha-Synuclein; Animals; Corpus Striatum; Disease Models, Animal; Disease Progression; Exc

2016
Rebamipide retards CCl4-induced hepatic fibrosis in rats: Possible role for PGE2.
    Journal of immunotoxicology, 2016, Volume: 13, Issue:4

    Topics: Alanine; Alanine Transaminase; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Carbo

2016
ALS mouse model SOD1G93A displays early pathology of sensory small fibers associated to accumulation of a neurotoxic splice variant of peripherin.
    Human molecular genetics, 2016, Apr-15, Volume: 25, Issue:8

    Topics: Alanine; Alternative Splicing; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Animals; Cell

2016
Age-dependent neuroinflammation and cognitive decline in a novel Ala152Thr-Tau transgenic mouse model of PSP and AD.
    Acta neuropathologica communications, 2016, Feb-25, Volume: 4

    Topics: Age Factors; Aging; Alanine; Alzheimer Disease; Animals; Astrocytes; Cognition Disorders; Cytokines;

2016
[Evaluation of Gastric Mucosal Injury Model Animals of Rebamipide Formulation--Study of Therapeutic Equivalence].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2016, Volume: 136, Issue:4

    Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Disease Models, Animal

2016
The Clostridium difficile Dlt Pathway Is Controlled by the Extracytoplasmic Function Sigma Factor σV in Response to Lysozyme.
    Infection and immunity, 2016, Volume: 84, Issue:6

    Topics: Alanine; Animals; Bacterial Proteins; Carrier Proteins; Cell Wall; Clostridioides difficile; Cricetu

2016
A Therapeutic Antibody for Cancer, Derived from Single Human B Cells.
    Cell reports, 2016, 05-17, Volume: 15, Issue:7

    Topics: Alanine; Animals; Antibodies, Monoclonal; Autoantibodies; B-Lymphocytes; Cell Line, Tumor; Cell Prol

2016
Preventive and alleviative effects of the dual enkephalinase inhibitor (Denki) PL265 in a murine model of neuropathic pain.
    European journal of pharmacology, 2016, Oct-05, Volume: 788

    Topics: Alanine; Animals; Biphenyl Compounds; Body Weight; Disease Models, Animal; Hyperalgesia; Male; Mice;

2016
Size effect of rebamipide ophthalmic nanodispersions on its therapeutic efficacy for corneal wound healing.
    Experimental eye research, 2016, Volume: 151

    Topics: Alanine; Animals; Antioxidants; Cell Line; Corneal Injuries; Disease Models, Animal; Epithelium, Cor

2016
Serine 421 regulates mutant huntingtin toxicity and clearance in mice.
    The Journal of clinical investigation, 2016, 09-01, Volume: 126, Issue:9

    Topics: Alanine; Animals; Aspartic Acid; Behavior, Animal; Chromosomes, Artificial, Bacterial; Disease Model

2016
In situ lactate dehydrogenase activity: a novel renal cortical imaging biomarker of tubular injury?
    American journal of physiology. Renal physiology, 2017, 03-01, Volume: 312, Issue:3

    Topics: Acute Kidney Injury; Alanine; Animals; Bicarbonates; Biomarkers; Carbon Isotopes; Disease Models, An

2017
Two novel alleles of tottering with distinct Ca(v)2.1 calcium channel neuropathologies.
    Neuroscience, 2008, Jul-31, Volume: 155, Issue:1

    Topics: Alanine; Animals; Animals, Newborn; Calbindins; Calcium Channels, N-Type; Cells, Cultured; Cysteine;

2008
Synthesis and biological evaluation of a focused library of beauveriolides.
    Bioorganic & medicinal chemistry letters, 2008, Aug-01, Volume: 18, Issue:15

    Topics: Alanine; Amino Acids; Animals; Atherosclerosis; Combinatorial Chemistry Techniques; Depsipeptides; D

2008
A gamma-secretase inhibitor and quinacrine reduce prions and prevent dendritic degeneration in murine brains.
    Proceedings of the National Academy of Sciences of the United States of America, 2008, Jul-29, Volume: 105, Issue:30

    Topics: Administration, Oral; Alanine; Amyloid Precursor Protein Secretases; Animals; Azepines; Brain; Dendr

2008
Control of acute, chronic, and constitutive hyperammonemia by wild-type and genetically engineered Lactobacillus plantarum in rodents.
    Hepatology (Baltimore, Md.), 2008, Volume: 48, Issue:4

    Topics: Acute Disease; Alanine; Ammonia; Animals; Carbon Tetrachloride; Chronic Disease; Disease Models, Ani

2008
Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading.
    Cancer research, 2008, Oct-15, Volume: 68, Issue:20

    Topics: Adenocarcinoma; Alanine; Animals; Biomarkers, Tumor; Carbon Isotopes; Disease Models, Animal; Lactic

2008
Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading.
    Cancer research, 2008, Oct-15, Volume: 68, Issue:20

    Topics: Adenocarcinoma; Alanine; Animals; Biomarkers, Tumor; Carbon Isotopes; Disease Models, Animal; Lactic

2008
Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading.
    Cancer research, 2008, Oct-15, Volume: 68, Issue:20

    Topics: Adenocarcinoma; Alanine; Animals; Biomarkers, Tumor; Carbon Isotopes; Disease Models, Animal; Lactic

2008
Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading.
    Cancer research, 2008, Oct-15, Volume: 68, Issue:20

    Topics: Adenocarcinoma; Alanine; Animals; Biomarkers, Tumor; Carbon Isotopes; Disease Models, Animal; Lactic

2008
Requirement of Notch activation during regeneration of the intestinal epithelia.
    American journal of physiology. Gastrointestinal and liver physiology, 2009, Volume: 296, Issue:1

    Topics: Alanine; Amyloid Precursor Protein Secretases; Animals; Azepines; Basic Helix-Loop-Helix Transcripti

2009
Selective noradrenergic vulnerability in α-synuclein transgenic mice.
    Neurobiology of aging, 2010, Volume: 31, Issue:12

    Topics: Alanine; alpha-Synuclein; Animals; Disease Models, Animal; Humans; Mice; Mice, Inbred C3H; Mice, Inb

2010
Non-nuclear Wld(S) determines its neuroprotective efficacy for axons and synapses in vivo.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2009, Jan-21, Volume: 29, Issue:3

    Topics: Age Factors; Alanine; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Arginine; Axons

2009
Effect of a dominant-negative form of ADAM10 in a mouse model of Alzheimer's disease.
    Journal of Alzheimer's disease : JAD, 2009, Volume: 16, Issue:2

    Topics: ADAM Proteins; ADAM10 Protein; Age Factors; Alanine; Alzheimer Disease; Amyloid beta-Protein Precurs

2009
Excitotoxicity-induced endocytosis confers drug targeting in cerebral ischemia.
    Annals of neurology, 2009, Volume: 65, Issue:3

    Topics: Alanine; Animals; Animals, Newborn; Brain Ischemia; Cells, Cultured; Cerebral Cortex; Dextrans; Dise

2009
Assessment of GS-9219 in a pet dog model of non-Hodgkin's lymphoma.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, May-15, Volume: 15, Issue:10

    Topics: Alanine; Animals; Animals, Domestic; Anorexia; Antineoplastic Agents; Area Under Curve; Diarrhea; Di

2009
The effects of group III mGluR ligands on pentylenetetrazol-induced kindling of seizures and hippocampal amino acids concentration.
    Brain research, 2009, Jul-28, Volume: 1282

    Topics: Alanine; Amino Acids; Aminobutyrates; Animals; Convulsants; Disease Models, Animal; Dose-Response Re

2009
Alpha-synuclein S129 phosphorylation mutants do not alter nigrostriatal toxicity in a rat model of Parkinson disease.
    Journal of neuropathology and experimental neurology, 2009, Volume: 68, Issue:5

    Topics: Alanine; alpha-Synuclein; Animals; Aspartic Acid; Basal Ganglia; Cell Count; Dependovirus; Disease M

2009
The proinflammatory action of microglial P2 receptors is enhanced in SOD1 models for amyotrophic lateral sclerosis.
    Journal of immunology (Baltimore, Md. : 1950), 2009, Oct-01, Volume: 183, Issue:7

    Topics: Alanine; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Animals; Cell Line, Transformed; Ce

2009
Blockade of Hsp20 phosphorylation exacerbates cardiac ischemia/reperfusion injury by suppressed autophagy and increased cell death.
    Circulation research, 2009, Dec-04, Volume: 105, Issue:12

    Topics: Alanine; Animals; Apoptosis; Autophagy; Base Sequence; Disease Models, Animal; Heart Failure; HSP20

2009
BMAA neurotoxicity in Drosophila.
    Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases, 2009, Volume: 10 Suppl 2

    Topics: Alanine; Amino Acids, Diamino; Analysis of Variance; Animals; Behavior, Animal; Chromatography, High

2009
Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice.
    Neuron, 2009, Dec-24, Volume: 64, Issue:6

    Topics: Alanine; Amino Acid Sequence; Amino Acid Substitution; Amyloid; Animals; Aspartic Acid; Disease Mode

2009
Mice expressing the A53T mutant form of human alpha-synuclein exhibit hyperactivity and reduced anxiety-like behavior.
    Journal of neuroscience research, 2010, Volume: 88, Issue:8

    Topics: Age Factors; Alanine; alpha-Synuclein; Analysis of Variance; Animals; Anxiety; Disease Models, Anima

2010
T(2) relaxation times of (13)C metabolites in a rat hepatocellular carcinoma model measured in vivo using (13)C-MRS of hyperpolarized [1-(13)C]pyruvate.
    NMR in biomedicine, 2010, Volume: 23, Issue:4

    Topics: Alanine; Animals; Carbon Isotopes; Carcinoma, Hepatocellular; Disease Models, Animal; Liver Neoplasm

2010
Activation of alpha4* nAChRs is necessary and sufficient for varenicline-induced reduction of alcohol consumption.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2010, Jul-28, Volume: 30, Issue:30

    Topics: Alanine; Alcohol Drinking; Analysis of Variance; Animals; Benzazepines; Central Nervous System Depre

2010
Simultaneous two-dimensional HPLC determination of free D-serine and D-alanine in the brain and periphery of mutant rats lacking D-amino-acid oxidase.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2011, Nov-01, Volume: 879, Issue:29

    Topics: Alanine; Animals; Brain Chemistry; Chromatography, High Pressure Liquid; D-Amino-Acid Oxidase; Disea

2011
Relationship between neuropathology and disease progression in the SOD1(G93A) ALS mouse.
    Experimental neurology, 2011, Volume: 227, Issue:2

    Topics: Alanine; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Di

2011
Decreased glutathione accelerates neurological deficit and mitochondrial pathology in familial ALS-linked hSOD1(G93A) mice model.
    Neurobiology of disease, 2011, Volume: 43, Issue:3

    Topics: Alanine; Amyotrophic Lateral Sclerosis; Animals; Cells, Cultured; Coculture Techniques; Disease Mode

2011
Hind limb muscle atrophy precedes cerebral neuronal degeneration in G93A-SOD1 mouse model of amyotrophic lateral sclerosis: a longitudinal MRI study.
    Experimental neurology, 2011, Volume: 231, Issue:1

    Topics: Alanine; Amyotrophic Lateral Sclerosis; Animals; Brain; Disease Models, Animal; Glycine; Hindlimb; H

2011
Synthesis, transport and antiviral activity of Ala-Ser and Val-Ser prodrugs of cidofovir.
    Bioorganic & medicinal chemistry letters, 2011, Jul-01, Volume: 21, Issue:13

    Topics: Administration, Oral; Alanine; Animals; Antiviral Agents; Cells, Cultured; Cidofovir; Cytomegaloviru

2011
13C-pyruvate imaging reveals alterations in glycolysis that precede c-Myc-induced tumor formation and regression.
    Cell metabolism, 2011, Jul-06, Volume: 14, Issue:1

    Topics: Alanine; Animals; Carbon Isotopes; Citric Acid Cycle; Disease Models, Animal; Gene Expression Profil

2011
Dopamine-depletion and increased α-synuclein load induce degeneration of cortical cholinergic fibers in mice.
    Journal of the neurological sciences, 2011, Nov-15, Volume: 310, Issue:1-2

    Topics: Acetylcholinesterase; Alanine; alpha-Synuclein; Analysis of Variance; Animals; bcl-2-Associated X Pr

2011
Severe dysfunction of respiratory chain and cholesterol metabolism in Atp7b(-/-) mice as a model for Wilson disease.
    Biochimica et biophysica acta, 2011, Volume: 1812, Issue:12

    Topics: Aconitate Hydratase; Adenosine Triphosphatases; Alanine; Animals; Brain; Carnitine; Cation Transport

2011
N-acetylcysteine normalizes neurochemical changes in the glutathione-deficient schizophrenia mouse model during development.
    Biological psychiatry, 2012, Jun-01, Volume: 71, Issue:11

    Topics: Acetylcysteine; Alanine; Animals; Aspartic Acid; Cerebral Cortex; Disease Models, Animal; Free Radic

2012
PGC-1α protects neurons and alters disease progression in an amyotrophic lateral sclerosis mouse model.
    Muscle & nerve, 2011, Volume: 44, Issue:6

    Topics: Alanine; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Di

2011
Pharmacological activity of a Bv8 analogue modified in position 24.
    British journal of pharmacology, 2012, Volume: 166, Issue:3

    Topics: Alanine; Amino Acid Substitution; Amphibian Proteins; Analgesics; Animals; Chemotaxis; CHO Cells; Cr

2012
Preliminary studies on the effect of rebamipide against the trypsin and egg-albumin induced experimental model of asthma.
    Acta pharmaceutica (Zagreb, Croatia), 2011, Volume: 61, Issue:4

    Topics: Alanine; Animals; Asthma; Disease Models, Animal; Female; Histamine Release; Male; Mice; Ovalbumin;

2011
Reduced expression of the μ opioid receptor in some, but not all, brain regions in mice with OPRM1 A112G.
    Neuroscience, 2012, Mar-15, Volume: 205

    Topics: Alanine; Amino Acid Substitution; Analgesics, Opioid; Animals; Disease Models, Animal; Down-Regulati

2012
Effects of the selective kainate receptor antagonist ACET on altered sensorimotor gating in a genetic model of reduced NMDA receptor function.
    Brain research, 2012, Mar-14, Volume: 1443

    Topics: Alanine; Animals; Antipsychotic Agents; Carrier Proteins; Disease Models, Animal; Gene Knockdown Tec

2012
Toxic role of K+ channel oxidation in mammalian brain.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2012, Mar-21, Volume: 32, Issue:12

    Topics: 2,2'-Dipyridyl; Age Factors; Alanine; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein

2012
A brain aggregate model gives new insights into the pathobiology and treatment of prion diseases.
    Journal of neuropathology and experimental neurology, 2012, Volume: 71, Issue:5

    Topics: Alanine; Animals; Azepines; Brain; Cathepsin D; Dendrites; Disease Models, Animal; Embryo, Mammalian

2012
Critical role of soluble amyloid-β for early hippocampal hyperactivity in a mouse model of Alzheimer's disease.
    Proceedings of the National Academy of Sciences of the United States of America, 2012, May-29, Volume: 109, Issue:22

    Topics: Age Factors; Alanine; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases

2012
Kv1.1 knock-in ataxic mice exhibit spontaneous myokymic activity exacerbated by fatigue, ischemia and low temperature.
    Neurobiology of disease, 2012, Volume: 47, Issue:3

    Topics: Alanine; Animals; Ataxia; Calcium; Calcium Signaling; Cold Temperature; Disease Models, Animal; Elec

2012
Group I mGluR antagonist rescues the deficit of D1-induced LTP in a mouse model of fragile X syndrome.
    Molecular neurodegeneration, 2012, May-28, Volume: 7

    Topics: Alanine; Animals; Cells, Cultured; Disease Models, Animal; Fragile X Mental Retardation Protein; Fra

2012
Effects of supplementation on food intake, body weight and hepatic metabolites in the citrin/mitochondrial glycerol-3-phosphate dehydrogenase double-knockout mouse model of human citrin deficiency.
    Molecular genetics and metabolism, 2012, Volume: 107, Issue:3

    Topics: Alanine; Animals; Body Weight; Cholestasis, Intrahepatic; Citrullinemia; Dietary Proteins; Disease M

2012
Terminal-restriction fragment length polymorphism (T-RFLP) analysis for changes in the gut microbiota profiles of indomethacin- and rebamipide-treated mice.
    Digestion, 2012, Volume: 86, Issue:3

    Topics: Alanine; Animals; Cecum; Disease Models, Animal; DNA, Bacterial; Drug Therapy, Combination; Female;

2012
Correlation of plasma amino acid concentrations and chondroprotective effects of glucosamine and fish collagen peptide on the development of osteoarthritis.
    The Journal of veterinary medical science, 2013, May-02, Volume: 75, Issue:4

    Topics: Alanine; Animals; Cartilage, Articular; Collagen; Disease Models, Animal; Female; Glucosamine; Histo

2013
Effects of glycine supplementation on myocardial damage and cardiac function after severe burn.
    Burns : journal of the International Society for Burn Injuries, 2013, Volume: 39, Issue:4

    Topics: Adenosine Triphosphate; Alanine; Analysis of Variance; Animals; Aspartate Aminotransferases; Biomark

2013
Staphylococcus aureus strains lacking D-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice.
    The Journal of infectious diseases, 2002, Jul-15, Volume: 186, Issue:2

    Topics: Alanine; alpha-Defensins; Animals; Anti-Bacterial Agents; Bacterial Proteins; Disease Models, Animal

2002
Altered long-term corticostriatal synaptic plasticity in transgenic mice overexpressing human CU/ZN superoxide dismutase (GLY(93)-->ALA) mutation.
    Neuroscience, 2003, Volume: 118, Issue:2

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Action Potentials; Alanine; Animals; Avo

2003
Nutritional benefits of enteral alanyl-glutamine supplementation on rat small intestinal damage induced by cyclophosphamide.
    Journal of gastroenterology and hepatology, 2003, Volume: 18, Issue:6

    Topics: Alanine; Amino Acid Transport Systems; Animals; Antineoplastic Agents, Alkylating; Biomarkers; Body

2003
Immunohistochemical study on the distribution of alpha-synuclein in the central nervous system of transgenic mice expressing a human Cu/Zn superoxide dismutase mutation.
    Neuroscience letters, 2003, May-22, Volume: 342, Issue:3

    Topics: Alanine; alpha-Synuclein; Animals; Central Nervous System; Disease Models, Animal; Glycine; Humans;

2003
The AMPA receptor antagonist NBQX prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis.
    Neuroscience letters, 2003, Jun-05, Volume: 343, Issue:2

    Topics: Age Factors; Alanine; Amyotrophic Lateral Sclerosis; Analysis of Variance; Animals; Behavior, Animal

2003
Open space swimming test to index antidepressant activity.
    Journal of neuroscience methods, 2003, Jun-15, Volume: 126, Issue:1

    Topics: Alanine; Animals; Antidepressive Agents; Behavior, Animal; Depression; Disease Models, Animal; Drug

2003
Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation.
    Journal of hematotherapy & stem cell research, 2003, Volume: 12, Issue:3

    Topics: Alanine; Animals; Cord Blood Stem Cell Transplantation; Disease Models, Animal; Disease Progression;

2003
Hyperexcitability of cultured spinal motoneurons from presymptomatic ALS mice.
    Journal of neurophysiology, 2004, Volume: 91, Issue:1

    Topics: Action Potentials; Alanine; Amyotrophic Lateral Sclerosis; Animals; Animals, Newborn; Disease Models

2004
The serotonin precursor 5-hydroxytryptophan delays neuromuscular disease in murine familial amyotrophic lateral sclerosis.
    Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases, 2003, Volume: 4, Issue:3

    Topics: 5-Hydroxytryptophan; Aging; Alanine; Amyotrophic Lateral Sclerosis; Animals; Animals, Newborn; Body

2003
alpha-Amino-3-hydroxy-5-methyl-isoxazole-4-propionate receptors in spinal cord motor neurons are altered in transgenic mice overexpressing human Cu,Zn superoxide dismutase (Gly93-->Ala) mutation.
    Neuroscience, 2003, Volume: 122, Issue:1

    Topics: Alanine; Amyotrophic Lateral Sclerosis; Animals; Cell Culture Techniques; Disease Models, Animal; El

2003
An altered self-peptide with superagonist activity blocks a CD8-mediated mouse model of type 1 diabetes.
    Journal of immunology (Baltimore, Md. : 1950), 2004, Jan-15, Volume: 172, Issue:2

    Topics: Adoptive Transfer; Alanine; Amino Acid Substitution; Animals; Autoantigens; CD8-Positive T-Lymphocyt

2004
An ALS mouse model with a permeable blood-brain barrier benefits from systemic cyclosporine A treatment.
    Journal of neurochemistry, 2004, Volume: 88, Issue:4

    Topics: Age Factors; Alanine; Amyotrophic Lateral Sclerosis; Animals; ATP Binding Cassette Transporter, Subf

2004
Metabolism of 13C-enriched D-fructose in hepatocytes from Goto-Kakizaki rats.
    International journal of molecular medicine, 2004, Volume: 13, Issue:5

    Topics: Alanine; Animals; Buffers; Carbon Isotopes; Cells, Cultured; Diabetes Mellitus, Type 2; Disease Mode

2004
Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis.
    Muscle & nerve, 2004, Volume: 29, Issue:5

    Topics: Alanine; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Fe

2004
Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis.
    Muscle & nerve, 2004, Volume: 29, Issue:5

    Topics: Alanine; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Fe

2004
Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis.
    Muscle & nerve, 2004, Volume: 29, Issue:5

    Topics: Alanine; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Fe

2004
Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis.
    Muscle & nerve, 2004, Volume: 29, Issue:5

    Topics: Alanine; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Fe

2004
Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis.
    Muscle & nerve, 2004, Volume: 29, Issue:5

    Topics: Alanine; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Fe

2004
Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis.
    Muscle & nerve, 2004, Volume: 29, Issue:5

    Topics: Alanine; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Fe

2004
Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis.
    Muscle & nerve, 2004, Volume: 29, Issue:5

    Topics: Alanine; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Fe

2004
Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis.
    Muscle & nerve, 2004, Volume: 29, Issue:5

    Topics: Alanine; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Fe

2004
Effects of high-intensity endurance exercise training in the G93A mouse model of amyotrophic lateral sclerosis.
    Muscle & nerve, 2004, Volume: 29, Issue:5

    Topics: Alanine; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Fe

2004
rBPI(10-193) is secreted by CHO cells and retains the activity of rBPI21.
    Journal of endotoxin research, 2004, Volume: 10, Issue:2

    Topics: Alanine; Amino Acid Substitution; Animals; Antimicrobial Cationic Peptides; Bacteremia; Blood Protei

2004
Creation of a mouse expressing defective human factor IX.
    Blood, 2004, Sep-15, Volume: 104, Issue:6

    Topics: Alanine; Animals; Antibodies; Antigens; Blood Coagulation; Cell Line; Disease Models, Animal; DNA; F

2004
Decreased activity and expression of intestinal oligopeptide transporter PEPT1 in rats with hyperthyroidism in vivo.
    Pharmaceutical research, 2004, Volume: 21, Issue:6

    Topics: Alanine; Animals; Carbon Radioisotopes; Dipeptides; Disease Models, Animal; Dose-Response Relationsh

2004
Vascular endothelial growth factor prolongs survival in a transgenic mouse model of ALS.
    Annals of neurology, 2004, Volume: 56, Issue:4

    Topics: Age Factors; Alanine; Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Glycine; Human

2004
Hepatic glycogen breakdown is implicated in the maintenance of plasma mannose concentration.
    American journal of physiology. Endocrinology and metabolism, 2005, Volume: 288, Issue:3

    Topics: Administration, Oral; Alanine; Animals; Arabinose; Blood Glucose; Chlorogenic Acid; Diabetes Mellitu

2005
Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease.
    Proceedings of the National Academy of Sciences of the United States of America, 2004, Dec-14, Volume: 101, Issue:50

    Topics: Alanine; alpha-Synuclein; Animals; Brain; Disease Models, Animal; Dopamine; Female; Gene Expression;

2004
Exacerbated synucleinopathy in mice expressing A53T SNCA on a Snca null background.
    Neurobiology of aging, 2005, Volume: 26, Issue:1

    Topics: Age Factors; Alanine; alpha-Synuclein; Animals; Behavior, Animal; Blotting, Western; Disease Models,

2005
Protective effect of intra-rectal administration of rebamipide on dextran sulfate sodium-induced rat colitis.
    Digestion, 2004, Volume: 70, Issue:4

    Topics: Administration, Rectal; Alanine; Animals; Anti-Ulcer Agents; Anticoagulants; Colitis; Dextran Sulfat

2004
Delineation of the minimal encephalitogenic epitope of proteolipid protein peptide(91-110) and critical residues required for induction of EAE in HLA-DR3 transgenic mice.
    Journal of neuroimmunology, 2005, Volume: 161, Issue:1-2

    Topics: Alanine; Animals; Apoproteins; Brain; Cell Proliferation; Cytokines; Disease Models, Animal; Dose-Re

2005
Tau phosphorylation increases in symptomatic mice overexpressing A30P alpha-synuclein.
    Experimental neurology, 2005, Volume: 192, Issue:2

    Topics: Age Factors; Alanine; alpha-Synuclein; Amino Acid Substitution; Animals; Antibodies, Monoclonal; Blo

2005
Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson's disease.
    Neurobiology of disease, 2005, Volume: 18, Issue:3

    Topics: Alanine; alpha-Synuclein; Animals; Brain; Disease Models, Animal; Energy Metabolism; Mice; Mice, Inb

2005
MRL/lpr mice have alterations in brain metabolism as shown with [1H-13C] NMR spectroscopy.
    Neurochemistry international, 2005, Volume: 47, Issue:1-2

    Topics: Alanine; Amino Acids; Animals; Brain; Brain Diseases, Metabolic; Brain Edema; Carbon Radioisotopes;

2005
Topiramate prevents excitotoxic damage in the newborn rodent brain.
    Neurobiology of disease, 2005, Volume: 20, Issue:3

    Topics: Alanine; Animals; Animals, Newborn; Brain; Cerebral Palsy; Disease Models, Animal; Dose-Response Rel

2005
COX-1 and COX-2 conversely promote and suppress ischemia-reperfusion gastric injury in mice.
    Scandinavian journal of gastroenterology, 2005, Volume: 40, Issue:8

    Topics: Alanine; Animals; Blotting, Western; Celiac Artery; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygena

2005
Direct autoradiographic evidence that rebamipide interacts with neutrophils in dextran sulfate sodium induced colitis in rats.
    Digestive diseases and sciences, 2005, Volume: 50 Suppl 1

    Topics: Administration, Oral; Alanine; Animals; Anti-Ulcer Agents; Colitis; Dextran Sulfate; Disease Models,

2005
Rebamipide enema is effective for treatment of experimental dextran sulfate sodium induced colitis in rats.
    Digestive diseases and sciences, 2005, Volume: 50 Suppl 1

    Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Colitis, Ulcerative; D

2005
The CD8+ T-cell response to an Epstein-Barr virus-related gammaherpesvirus infecting rhesus macaques provides evidence for immune evasion by the EBNA-1 homologue.
    Journal of virology, 2005, Volume: 79, Issue:20

    Topics: Alanine; Animals; CD8-Positive T-Lymphocytes; Disease Models, Animal; Epitopes, T-Lymphocyte; Epstei

2005
Alcohol potently modulates climbing fiber-->Purkinje neuron synapses: role of metabotropic glutamate receptors.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2006, Feb-15, Volume: 26, Issue:7

    Topics: Alanine; Animals; Aspartic Acid; Disease Models, Animal; Ethanol; Long-Term Synaptic Depression; Mal

2006
Animal model of oculopharyngeal muscular dystrophy.
    Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology, 2005, Volume: 24, Issue:2

    Topics: Actins; Alanine; Animals; Disease Models, Animal; Inclusion Bodies; Mice; Mice, Transgenic; Muscle,

2005
Differential changes of group II and group III mGluR function in central amygdala neurons in a model of arthritic pain.
    Journal of neurophysiology, 2006, Volume: 96, Issue:4

    Topics: Alanine; Aminobutyrates; Amygdala; Animals; Arthritis; Bridged Bicyclo Compounds; Disease Models, An

2006
A truncated Bacillus subtilis dal gene with a 3' ssrA gene tag regulates the growth and virulence of racemase-deficient Listeria monocytogenes.
    Microbiology (Reading, England), 2006, Volume: 152, Issue:Pt 10

    Topics: Alanine; Alanine Racemase; Animals; Bacillus subtilis; CD8-Positive T-Lymphocytes; Cell Line; Cytopl

2006
Effect of rebamipide on the colonic barrier in interleukin-10-deficient mice.
    Digestive diseases and sciences, 2007, Volume: 52, Issue:1

    Topics: Alanine; Animals; Anti-Ulcer Agents; Colon; Disease Models, Animal; Female; Flow Cytometry; Helicoba

2007
Neutral Na-amino acid cotransport is differentially regulated by glucocorticoids in the normal and chronically inflamed rabbit small intestine.
    American journal of physiology. Gastrointestinal and liver physiology, 2007, Volume: 292, Issue:2

    Topics: Alanine; Amino Acid Transport System ASC; Animals; Cell Membrane; Disease Models, Animal; Enteritis;

2007
S/P and T/P phosphorylation is critical for tau neurotoxicity in Drosophila.
    Journal of neuroscience research, 2007, May-01, Volume: 85, Issue:6

    Topics: Alanine; Animals; Animals, Genetically Modified; Disease Models, Animal; Drosophila; Drosophila Prot

2007
The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo.
    The Journal of clinical investigation, 2007, Volume: 117, Issue:7

    Topics: Alanine; Animals; Aspartic Acid; Brain Ischemia; Cerebral Arteries; Disease Models, Animal; Gene Exp

2007
BACE1 and mutated presenilin-1 differently modulate Abeta40 and Abeta42 levels and cerebral amyloidosis in APPDutch transgenic mice.
    Neuro-degenerative diseases, 2007, Volume: 4, Issue:2-3

    Topics: Alanine; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases

2007
[Soluble CD40 ligand: a potential marker of cardiovascular risk].
    Revista clinica espanola, 2007, Volume: 207, Issue:8

    Topics: Abciximab; Acute Coronary Syndrome; Alanine; Angina, Unstable; Animals; Antibodies, Monoclonal; Anti

2007
Interaction between murine spf-ash mutation and genetic background yields different metabolic phenotypes.
    American journal of physiology. Endocrinology and metabolism, 2007, Volume: 293, Issue:6

    Topics: Alanine; Ammonia; Animals; Arginine; Citrulline; Disease Models, Animal; Female; Glycine; Injections

2007
1H NMR-based metabolomic analysis of liver, serum, and brain following ethanol administration in rats.
    Chemical research in toxicology, 2008, Volume: 21, Issue:2

    Topics: Alanine; Alcoholic Intoxication; Animals; Antioxidants; Brain; Butylated Hydroxytoluene; Central Ner

2008
Oral delivery of L-arginine stimulates prostaglandin-dependent secretory diarrhea in Cryptosporidium parvum-infected neonatal piglets.
    Journal of pediatric gastroenterology and nutrition, 2008, Volume: 46, Issue:2

    Topics: Alanine; Analysis of Variance; Animals; Animals, Newborn; Arginine; Atrophy; Chlorides; Cryptosporid

2008
Effective treatment with oral administration of rebamipide in a mouse model of Sjögren's syndrome.
    Arthritis and rheumatism, 2008, Volume: 58, Issue:2

    Topics: Administration, Oral; Alanine; Animals; Anti-Inflammatory Agents; Autoantibodies; Cell Division; Cyt

2008
Proteasomes remain intact, but show early focal alteration in their composition in a mouse model of amyotrophic lateral sclerosis.
    Journal of neurochemistry, 2008, Jun-01, Volume: 105, Issue:6

    Topics: Alanine; Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Glycine; Humans; Mice; Mice

2008
Tissue inhibitor of metalloproteinases-3 (TIMP-3) expression is increased during serum deprivation-induced neuronal apoptosis in vitro and in the G93A mouse model of amyotrophic lateral sclerosis: a potential modulator of Fas-mediated apoptosis.
    Neurobiology of disease, 2008, Volume: 30, Issue:2

    Topics: Alanine; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Animals; Apoptosis; Cell Line, Tumo

2008
Characterisation of electrogenic nutrient absorption in the Cftr TgH(neoim)Hgu mouse model.
    Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology, 2008, Volume: 178, Issue:6

    Topics: Alanine; Animals; Biological Transport; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance R

2008
Vulnerability of gastric mucosa to prednisolone in rats chronically exposed to cigarette smoke.
    Journal of pharmacological sciences, 2008, Volume: 106, Issue:4

    Topics: Alanine; Animals; Anti-Ulcer Agents; Blood Gas Analysis; Dinoprostone; Disease Models, Animal; Gastr

2008
Long-term prevention of Alzheimer's disease-like behavioral deficits in PDAPP mice carrying a mutation in Asp664.
    Behavioural brain research, 2008, Aug-22, Volume: 191, Issue:2

    Topics: Age Factors; Alanine; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Anal

2008
Metabolism and transport of L-glutamine and L-alanine by renal tubules of chickens.
    The American journal of physiology, 1983, Volume: 245, Issue:2

    Topics: Acidosis, Respiratory; Alanine; Alkalosis, Respiratory; Animals; Biological Transport; Carbon Dioxid

1983
Morphological and functional changes in the gut after massive small bowel resection and colon interposition in rhesus monkeys.
    Digestion, 1984, Volume: 29, Issue:1

    Topics: Adaptation, Physiological; Alanine; Animals; Colon; Disease Models, Animal; Glucose; Hyperplasia; Hy

1984
Jejunal transport properties of piebald mouse model for Hirschsprung's disease.
    The American journal of physiology, 1980, Volume: 239, Issue:2

    Topics: Alanine; Amino Acids; Animals; Biological Transport, Active; Disease Models, Animal; Female; Jejunum

1980
Changes in alanine turnover rate due to nutritional and genetic obesity in the rat.
    Biochemistry and molecular biology international, 1994, Volume: 34, Issue:1

    Topics: Alanine; Analysis of Variance; Animals; Body Weight; Diet; Disease Models, Animal; Energy Intake; Ma

1994
Effects of rotavirus on epithelial transport in rabbit small intestine.
    Digestive diseases and sciences, 1994, Volume: 39, Issue:10

    Topics: Alanine; Animals; Biological Transport; Cells, Cultured; Diarrhea; Dinoprostone; Disease Models, Ani

1994
Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 270, Issue:1

    Topics: Alanine; Amino Acid Sequence; Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Atri

1994
Subchronic toxicity of 3-phenylamino alanine, an impurity in L-tryptophan reported to be associated with eosinophilia-myalgia syndrome.
    Archives of toxicology, 1995, Volume: 69, Issue:7

    Topics: Administration, Oral; Alanine; Animals; Blood Chemical Analysis; Brain; Chromatography, High Pressur

1995
Glucose metabolism distal to a critical coronary stenosis in a canine model of low-flow myocardial ischemia.
    The Journal of clinical investigation, 1996, Jul-01, Volume: 98, Issue:1

    Topics: Alanine; Animals; Coronary Disease; Coronary Vessels; Disease Models, Animal; Dogs; Endocardium; Fat

1996
Inhibition of both angiotensin-converting enzyme and neutral endopeptidase by S21402 (RB105) in rats with experimental myocardial infarction.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 278, Issue:2

    Topics: Alanine; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Disease Models, Animal;

1996
The biochemical basis of increased hepatic glucose production in a mouse model of type 2 (non-insulin-dependent) diabetes mellitus.
    Diabetologia, 1995, Volume: 38, Issue:12

    Topics: Alanine; Animals; Body Mass Index; Diabetes Mellitus; Diabetes Mellitus, Type 2; Dietary Fats; Disea

1995
Dietary glutamine supplementation prevents jejunal atrophy in weaned pigs.
    The Journal of nutrition, 1996, Volume: 126, Issue:10

    Topics: Alanine; Animals; Aspartic Acid; Atrophy; Diet; Disease Models, Animal; Duodenum; Epithelium; Female

1996
Impairment of antioxidants in colonic epithelial cells isolated from trinitrobenzene sulphonic acid-induced colitis rats. Protective effect of rebamipide.
    Scandinavian journal of gastroenterology, 1996, Volume: 31, Issue:10

    Topics: Alanine; Analysis of Variance; Animals; Anti-Ulcer Agents; Antioxidants; Colitis; Culture Techniques

1996
Effects of rebamipide on bile acid-induced inhibition of gastric epithelial repair in a rabbit cell culture model.
    Alimentary pharmacology & therapeutics, 1996, Volume: 10, Issue:6

    Topics: Actins; Alanine; Animals; Anti-Ulcer Agents; Bromodeoxyuridine; Cell Division; Cell Movement; Cells,

1996
Treatment with growth hormone and insulin-like growth factor-1 in septicemia: effects on carbohydrate metabolism.
    European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes, 1998, Volume: 30, Issue:2

    Topics: Alanine; Animals; Bacteremia; Blood Glucose; Calorimetry, Indirect; Carbohydrate Metabolism; Disease

1998
Changes in brain organic osmolytes in experimental cerebral ischemia.
    Journal of the neurological sciences, 1998, Apr-15, Volume: 157, Issue:1

    Topics: Alanine; Amino Acids; Animals; Aspartic Acid; Brain Chemistry; Brain Ischemia; Creatine; Disease Mod

1998
Studies of arginine metabolism and salt sensitivity in the Dahl/Rapp rat models of hypertension.
    Molecular genetics and metabolism, 1998, Volume: 64, Issue:1

    Topics: Alanine; Animals; Arginine; Argininosuccinate Synthase; Blood Pressure; Body Weight; Citrulline; Dis

1998
Rebamipide treatment activates epidermal growth factor and its receptor expression in normal and ulcerated gastric mucosa in rats: one mechanism for its ulcer healing action?
    Digestive diseases and sciences, 1998, Volume: 43, Issue:9 Suppl

    Topics: Alanine; Animals; Anti-Ulcer Agents; Disease Models, Animal; Epidermal Growth Factor; ErbB Receptors

1998
Effect of rebamipide on liver damage and increased tumor necrosis factor in a rat model of endotoxin shock.
    Digestive diseases and sciences, 1998, Volume: 43, Issue:9 Suppl

    Topics: Alanine; Animals; Disease Models, Animal; Enzyme Inhibitors; Escherichia coli; Lipopolysaccharides;

1998
Inhibitory effects of rebamipide on ENNG-induced duodenal carcinogenesis in mice: a possible strategy for chemoprevention of gastrointestinal cancers.
    Digestive diseases and sciences, 1998, Volume: 43, Issue:9 Suppl

    Topics: Alanine; Animals; Antineoplastic Agents; Carcinogens; Disease Models, Animal; Dose-Response Relation

1998
Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis.
    Nature medicine, 1999, Volume: 5, Issue:3

    Topics: Alanine; Amyotrophic Lateral Sclerosis; Animals; Creatine; Disease Models, Animal; Glycine; Humans;

1999
Anticonvulsant activity of PNU-151774E in the amygdala kindled model of complex partial seizures.
    Epilepsia, 1999, Volume: 40, Issue:11

    Topics: Acetates; Alanine; Amines; Amygdala; Animals; Anticonvulsants; Behavior, Animal; Benzylamines; Carba

1999
Antiplatelet and antithrombotic effects of orbofiban, a new orally active GPIIb/IIIa antagonist, in guinea pigs.
    Thrombosis research, 2000, Mar-01, Volume: 97, Issue:5

    Topics: Adenosine Diphosphate; Administration, Oral; Alanine; Animals; Arteriovenous Shunt, Surgical; Aspiri

2000
Neuroprotective effects of kynurenine-3-hydroxylase inhibitors in models of brain ischemia.
    Advances in experimental medicine and biology, 1999, Volume: 467

    Topics: Alanine; Animals; Brain Ischemia; Cerebral Infarction; Disease Models, Animal; Enzyme Inhibitors; Ge

1999
Activation and response to axotomy of microglia in the facial motor nuclei of G93A superoxide dismutase transgenic mice.
    Neuroscience letters, 2000, May-12, Volume: 285, Issue:2

    Topics: Alanine; Amyotrophic Lateral Sclerosis; Animals; Axotomy; Disease Models, Animal; Facial Nerve; Glyc

2000
Positive effect of rebamipide on gastric permeability in mice after eradication of Helicobacter felis.
    Scandinavian journal of gastroenterology, 2000, Volume: 35, Issue:5

    Topics: Alanine; Animals; Anti-Ulcer Agents; Disease Models, Animal; Gastric Mucosa; Helicobacter; Helicobac

2000
Rebamipide, an antiulcer drug, prevents DSS-induced colitis formation in rats.
    Digestive diseases and sciences, 2000, Volume: 45, Issue:8

    Topics: Alanine; Animals; Anti-Ulcer Agents; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Interl

2000
Sequence of normal canine COL1A1 cDNA and identification of a heterozygous alpha1(I) collagen Gly208Ala mutation in a severe case of canine osteogenesis imperfecta.
    Archives of biochemistry and biophysics, 2000, Dec-01, Volume: 384, Issue:1

    Topics: Alanine; Amino Acid Sequence; Animals; Base Sequence; Collagen; Collagen Type I; Collagen Type I, al

2000
In vitro 1H and 31P NMR spectroscopic evidence of multiple aberrant biochemical pathways in murine trisomy 16 brain development.
    International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience, 2000, Volume: 18, Issue:8

    Topics: Alanine; Animals; Aspartic Acid; Biomarkers; Brain Chemistry; Choline; Creatine; Disease Models, Ani

2000
Boronated dipeptide borotrimethylglycylphenylalanine as a potential boron carrier in boron neutron capture therapy for malignant brain tumors.
    Radiation research, 2001, Volume: 156, Issue:1

    Topics: Alanine; Animals; Autoradiography; Boron Compounds; Boron Neutron Capture Therapy; Brain; Brain Neop

2001
Experimental colitis decreases rat jejunal amino acid absorption: role of capsaicin sensitive primary afferents.
    Life sciences, 2001, Nov-09, Volume: 69, Issue:25-26

    Topics: Afferent Pathways; Alanine; Animals; Animals, Newborn; Capsaicin; Colitis; Denervation; Disease Mode

2001
Striatal AMPA receptor binding is unaltered in the MPTP-lesioned macaque model of Parkinson's disease and dyskinesia.
    Experimental neurology, 2002, Volume: 174, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Alanine; Animals; Apomorphine; Autoradiography; Bindin

2002
Glutamine concentration and tissue exchange with intravenously administered alpha-ketoglutaric acid and ammonium: a dose-response study in the pig.
    Nutrition (Burbank, Los Angeles County, Calif.), 2002, Volume: 18, Issue:6

    Topics: Acidosis; Alanine; Amino Acids; Animals; Blood Gas Analysis; Disease Models, Animal; Dose-Response R

2002
Effect of amino-oxyacetic acid (AOAA) on focal penicillin seizures.
    Brain research, 1978, Nov-24, Volume: 157, Issue:2

    Topics: Acetates; Alanine; Aminooxyacetic Acid; Animals; Aspartic Acid; Cerebral Cortex; Disease Models, Ani

1978
Fine structure of the Legionnaires' disease bacterium. In-vitro and in-vivo studies of four isolates.
    Annals of internal medicine, 1979, Volume: 90, Issue:4

    Topics: Alanine; Animals; Bacteria; Cell Membrane; Cell Wall; Diaminopimelic Acid; Disease Models, Animal; G

1979
The mechanism of hypoglycemia due to semistarvation in the rat.
    The Journal of nutrition, 1976, Volume: 106, Issue:11

    Topics: Alanine; Animals; Blood Glucose; Disease Models, Animal; Energy Metabolism; Glucagon; Glucose; Glyce

1976
Fasting-induced hypoglycemia in experimentally malnourished rats.
    The Journal of nutrition, 1977, Volume: 107, Issue:3

    Topics: Adaptation, Physiological; Alanine; Aminobutyrates; Animals; Brain Chemistry; Disease Models, Animal

1977
Contents of several amino acids in the cerebellum, brain stem and cerebrum of the 'staggerer', 'weaver' and 'nervous' neurologically mutant mice.
    Journal of neurochemistry, 1976, Volume: 26, Issue:5

    Topics: Alanine; Amino Acids; Animals; Aspartic Acid; Brain; Brain Diseases; Brain Stem; Cerebellum; Disease

1976
Therapeutic effects of oral rebamipide and in combination with cimetidine on experimental gastritis in rats.
    Research communications in chemical pathology and pharmacology, 1992, Volume: 78, Issue:3

    Topics: Administration, Oral; Alanine; Animals; Anti-Ulcer Agents; Cimetidine; Disease Models, Animal; Drug

1992
Chronic hypoxia in neuronal cell culture: metabolic consequences.
    Brain & development, 1990, Volume: 12, Issue:3

    Topics: Alanine; Animals; Bicarbonates; Binding, Competitive; Brain Chemistry; Cell Hypoxia; Cells, Cultured

1990
Alanine stimulation of water and sodium absorption in a model of secretory diarrhea.
    Journal of pediatric gastroenterology and nutrition, 1990, Volume: 10, Issue:2

    Topics: Absorption; Alanine; Animals; Diarrhea; Disease Models, Animal; Fluid Therapy; Intestinal Absorption

1990
Lathyrism: evidence for role of the neuroexcitatory aminoacid BOAA.
    Lancet (London, England), 1986, Nov-08, Volume: 2, Issue:8515

    Topics: Adolescent; Adult; Alanine; Amino Acids, Diamino; Animals; beta-Alanine; Central Nervous System; Chi

1986
Alterations of fasting glucose and fat metabolism in intrauterine growth-retarded newborn dogs.
    The American journal of physiology, 1989, Volume: 256, Issue:3 Pt 1

    Topics: Aging; Alanine; Animals; Animals, Newborn; Blood Glucose; Disease Models, Animal; Dogs; Energy Metab

1989
Relationship between elastolytic acitivity and experimental emphysema-induced properties of papain preparations.
    The American review of respiratory disease, 1974, Volume: 110, Issue:3

    Topics: Alanine; Animals; Arginine; Benzoates; Butanols; Cricetinae; Disease Models, Animal; Elastic Tissue;

1974
Concentration of amino acids in the brain of cobalt-epileptic rat.
    Epilepsia, 1973, Volume: 14, Issue:4

    Topics: Alanine; Amino Acids; Animals; Aspartic Acid; Brain Chemistry; Cerebral Cortex; Cobalt; Disease Mode

1973
Absolute levels of some free amino acids in normal and biologically fractionated retinas.
    Investigative ophthalmology, 1973, Volume: 12, Issue:9

    Topics: Adaptation, Ocular; Alanine; Amino Acids; Aminobutyrates; Animals; Autoanalysis; Dark Adaptation; Di

1973
Some kinetic properties of the allosteric M-type pyruvate kinase from rat liver; influence of pH and the nature of amino acid inhibition.
    Biochimica et biophysica acta, 1973, Sep-15, Volume: 321, Issue:1

    Topics: Adenosine Triphosphate; Alanine; Allosteric Regulation; Animals; Binding Sites; Disease Models, Anim

1973
Plasma amino acids in experimental acute hepatic failure and their relationship to brain tryptophan.
    Clinical science and molecular medicine, 1974, Volume: 46, Issue:4

    Topics: Acute Disease; Alanine; Amino Acids; Animals; Brain Chemistry; Disease Models, Animal; Glycine; Hepa

1974
[Behavior of serum amino acids in rats with experimentally produced hyperphenylalaninemia].
    Acta biologica et medica Germanica, 1971, Volume: 26, Issue:5

    Topics: Alanine; Amino Acids; Animals; Disease Models, Animal; Glutamates; Phenylalanine; Proline; Rats; Thr

1971